""	"response_component"	"curation_date"	"cohort"	"age_min"	"age_max"	"age_units"	"number_subjects"	"tissue_type"	"tissue_type_term_id"	"response_component_original"	"response_behavior_type"	"response_behavior"	"comparison"	"baseline_time_event"	"time_point"	"time_point_units"	"exposure_material"	"exposure_material_id"	"additional_exposure_material"	"target_pathogen"	"vaccine_year"	"adjuvant"	"route"	"scheduling"	"publication_reference_id"	"publication_date"	"publication_reference_url"	"signature_source"	"signature_source_url"	"comments"	"cell_ontology_id"	"pro_ontology_id"	"response_comp_orig_cnt"	"response_comp_cnt"	"subm_obs_id"	"uniq_obs_id"	"row_key"
"subject"	"cell_subset"	""	""	""	""	""	""	"cell_subset"	""	""	""	""	""	""	""	""	""	"vaccine"	""	"pathogen"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"evidence"	""	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"
"role"	"cell_biomarker"	"background"	"observed"	"observed"	"observed"	"observed"	"observed"	"tissue"	"background"	"observed"	"background"	"measured"	"background"	"background"	"observed"	"observed"	"background"	"vaccine"	"background"	"pathogen"	"background"	"background"	"background"	"background"	"background"	"background"	"reference"	"background"	"background"	"background"	"observed"	"observed"	"observed"	"observed"	"background"	"background"	"background"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	"response component"	"curation date (YYYY-MM-DD) "	"cohort - any characteristics of the population(s) studied, plus whether the result was taken from a subgroup of the broader cohort tested."	"age_min - age of youngest subject including both cases and controls"	"age_max - age of oldest subject including both cases and controls"	"age units"	"number of subjects - count of case plus control subjects used in the measurement"	"tissue type"	"Cell Ontology ID of tissue"	"response component (original curated cell type)"	"response behavior type"	"response behavior (direction, correlation type etc.)"	"comparison (affected vs control, correlated variable, time vs baseline event etc.)"	"baseline time event"	"time point relative to baseline event at which response was measured"	"time point units"	"exposure material (vaccine name)"	"exposure material"	"additional exposure material"	"target pathogen"	"vaccine year"	"adjuvant"	"route"	"scheduling"	"publication reference (PMID)"	"print publication date or posted date (YYYY-MM-DD or YYYY)"	"publication url"	"signature source figure, table or text section"	"signature source url"	"comments and additional details"	"response component cell ontology ID"	"response component marker protein ontology ID"	"response component (original) count"	"response component count"	"ID of observation within a publication (PMID) and for its submission type "	"ID of observation within its submission type"	"row key"
""	"antibody secreting cell"	""	""	"18"	"45"	"years"	""	"blood"	"UBERON:0000178"	"antibody secreting cell"	"cell type frequency"	"up"	"Menactra vs Menomune"	"time of vaccination (first dose)"	"7"	"days"	"Menactra; Menomune"	"VO:0000071; VO:0000072"	""	"neisseria meningitidis"	""	""	""	""	"24336226"	"2014"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226"	"Fig 1F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/"	""	"CL:0000946"	""	"1"	"1"	"1"	"8"	"24336226_1_8"
""	"antibody secreting cell"	""	""	"18"	"45"	"years"	""	"blood"	"UBERON:0000178"	"antibody secreting cell"	"cell type frequency"	"up"	"d7 vs d0"	"time of vaccination (first dose)"	"7"	"days"	"Menactra"	"VO:0000071"	""	"neisseria meningitidis"	""	""	""	""	"24336226"	"2014"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226"	"Fig 1F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/"	""	"CL:0000946"	""	"1"	"1"	"2"	"9"	"24336226_2_9"
""	"antibody secreting cell"	""	""	"18"	"45"	"years"	""	"blood"	"UBERON:0000178"	"antibody secreting cell"	"cell type frequency"	"up"	"d30 vs d0"	"time of vaccination (first dose)"	"30"	"days"	"Menactra"	"VO:0000071"	""	"neisseria meningitidis"	""	""	""	""	"24336226"	"2014"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226"	"Fig 1F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/"	""	"CL:0000946"	""	"1"	"1"	"3"	"10"	"24336226_3_10"
""	"antibody secreting cell"	""	""	"18"	"45"	"years"	""	"blood"	"UBERON:0000178"	"antibody secreting cell"	"cell type frequency"	"up"	"d7 vs d0"	"time of vaccination (first dose)"	"7"	"days"	"Menomune"	"VO:0000072"	""	"neisseria meningitidis"	""	""	""	""	"24336226"	"2014"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226"	"Fig 1F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/"	""	"CL:0000946"	""	"1"	"1"	"4"	"11"	"24336226_4_11"
""	"antibody secreting cell"	""	""	"18"	"45"	"years"	""	"blood"	"UBERON:0000178"	"antibody secreting cell"	"cell type frequency"	"positively correlated"	"d7 serum anti-DT IgG"	"time of vaccination (first dose)"	"7"	"days"	"Menactra"	"VO:0000071"	""	"neisseria meningitidis"	""	""	""	""	"24336226"	"2014"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226"	"Fig 1G"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/"	""	"CL:0000946"	""	"1"	"1"	"5"	"12"	"24336226_5_12"
""	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell"	""	"young (20–30 years), older (60 to >89 years)"	"20"	"89"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell"	"cell type frequency"	"negatively predictive"	"d28 HAI"	"time of vaccination (first dose)"	"0"	"days"	"Fluzone"	"VO:0000047"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	""	""	""	"23591775"	"2013"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775"	"Fig 5"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/figure/f5/"	""	"CL:0000904"	""	"2"	"2"	"1"	"13"	"23591775_1_13"
""	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell; CD8-positive, CD28-negative, alpha-beta regulatory T cell; natural killer cell"	""	"young (20–30 years), older (60 to >89 years), subgroup good responders"	"20"	"89"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell; CD8-positive, CD28-negative, alpha-beta regulatory T cell; natural killer cell"	"cell type frequency"	"negatively predictive"	"d28 HAI"	"time of vaccination (first dose)"	"0"	"days"	"Fluzone"	"VO:0000047"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	""	""	""	"23591775"	"2013"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775"	"Suppl Fig 3"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/#S1"	""	"CL:0000904"	""	"4"	"4"	"2"	"14"	"23591775_2_14"
""	"naive thymus-derived CD8-positive, alpha-beta T cell"	""	"young (20–30 years), older (60 to >89 years), subgroup good responders"	"20"	"89"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"naive thymus-derived CD8-positive, alpha-beta T cell"	"cell type frequency"	"positively predictive"	"d28 HAI"	"time of vaccination (first dose)"	"0"	"days"	"Fluzone"	"VO:0000047"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	""	""	""	"23591775"	"2013"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775"	"Suppl Fig 3"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/#S1"	""	"CL:0000900"	""	"1"	"1"	"3"	"15"	"23591775_3_15"
""	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell"	""	"young (20–30 years), older (60 to >89 years)"	"20"	"89"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell"	"cell type frequency"	"negatively predictive"	"d28 HAI"	"time of vaccination (first dose)"	"28"	"days"	"Fluzone"	"VO:0000047"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	""	""	""	"23591775"	"2013"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775"	"Fig 5"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/figure/f5/"	""	"CL:0000904"	""	"2"	"2"	"4"	"16"	"23591775_4_16"
""	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell; CD8-positive, CD28-negative, alpha-beta regulatory T cell; natural killer cell"	""	"young (20–30 years), older (60 to >89 years)"	"20"	"89"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell; CD8-positive, CD28-negative, alpha-beta regulatory T cell; natural killer cell"	"cell type frequency"	"negatively predictive"	"d28 HAI"	"time of vaccination (first dose)"	"28"	"days"	"Fluzone"	"VO:0000047"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	""	""	""	"23591775"	"2013"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775"	"Fig 7"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/figure/f7/"	""	"CL:0000904"	""	"4"	"4"	"5"	"17"	"23591775_5_17"
""	"naive thymus-derived CD8-positive, alpha-beta T cell"	""	"young (20–30 years), older (60 to >89 years)"	"20"	"89"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"naive thymus-derived CD8-positive, alpha-beta T cell"	"cell type frequency"	"positively predictive"	"d28 HAI"	"time of vaccination (first dose)"	"28"	"days"	"Fluzone"	"VO:0000047"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	""	""	""	"23591775"	"2013"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775"	"Fig 7"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/figure/f7/"	""	"CL:0000900"	""	"1"	"1"	"6"	"18"	"23591775_6_18"
""	"plasmablast"	""	""	"18"	"64"	"years"	""	"blood"	"UBERON:0000178"	"plasmablast"	"cell type frequency"	"up"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Pneumovax 23"	"VO:0000088"	""	"streptococcus pneumoniae"	""	""	""	""	"23601689"	"2013"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23601689"	"Fig 6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681204/figure/F6/"	""	"CL:0000980"	""	"1"	"1"	"1"	"19"	"23601689_1_19"
""	"plasmablast"	""	""	"18"	"64"	"years"	""	"blood"	"UBERON:0000178"	"plasmablast"	"cell type frequency"	"up"	"10d vs 0d"	"time of vaccination (first dose)"	"10"	"days"	"Pneumovax 23"	"VO:0000088"	""	"streptococcus pneumoniae"	""	""	""	""	"23601689"	"2013"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23601689"	"Fig 6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681204/figure/F6/"	""	"CL:0000980"	""	"1"	"1"	"2"	"20"	"23601689_2_20"
""	"plasmablast"	""	""	"18"	"64"	"years"	""	"blood"	"UBERON:0000178"	"plasmablast"	"cell type frequency"	"up"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Fluzone"	"VO:0000047"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2009"	""	""	""	"23601689"	"2013"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23601689"	"Fig 6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681204/figure/F6/"	""	"CL:0000980"	""	"1"	"1"	"3"	"21"	"23601689_3_21"
""	"natural killer cell & CD56-bright"	""	""	"18"	"55"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD56-bright natural killer (NK) cells"	"cell type frequency"	"positively correlated"	"antibody response at 28d and onward"	"time of vaccination (first dose)"	"3"	"days"	"rVSV-EBOV"	"VO:0004660"	""	"ebola virus"	""	""	""	""	"28854372"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/"	"Fig 4"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/figure/fig4/"	""	"CL:0000623"	"PR:000001024"	"1"	"1"	"1"	"22"	"28854372_1_22"
""	"IgG memory B cell & CD3-, CD19+, CD27+, HLADR+, IgG+; IgG memory B cell & CD3-, CD19+, CD27+, CD10-, CD20+, HLADR+, IgG+"	""	""	"18"	"55"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"switched IgG+ memory B cells (CD3-, CD19+, HLADR+, CD27+, IgG+); IgG+ memory B cells (CD3-, CD19+, HLADR+, CD27+, CD10-, CD20+, IgG+)"	"cell type frequency"	"negatively correlated"	"antibody response at 28d and onward"	"time of vaccination (first dose)"	"3"	"days"	"rVSV-EBOV"	"VO:0004660"	""	"ebola virus"	""	""	""	""	"28854372"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/"	"Fig 4"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/figure/fig4/"	""	"CL:0000979"	"PR:000001020, PR:000001002, PR:000001963"	"2"	"2"	"2"	"23"	"28854372_2_23"
""	"myeloid dendritic cell & CD86-positive; myeloid dendritic cell & CCR7+; monocyte & CD40, CD86; natural killer cell & CD38+, CD56-dim"	""	""	"18"	"55"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD86+ myeloid dendritic cells (mDCs); CCR7+ myeloid dendritic cells (mDCs); CD40/CD86+ monocytes; CD38+ CD56-dim natural killer (NK) cells"	"cell type frequency"	"up"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"rVSV-EBOV"	"VO:0004660"	""	"ebola virus"	""	""	""	""	"28854372"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/"	"Fig 2A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/figure/fig2/"	""	"CL:0000782"	"PR:000001412"	"4"	"4"	"3"	"24"	"28854372_3_24"
""	"plasmacytoid dendritic cell & CD40+, CD86+; myeloid dendritic cell & CD86-positive; monocyte & CD86-positive, CD16-positive, inflammatory; monocyte & CD40, CD86; monocyte & CD16-positive, inflammatory; natural killer cell & CD38+, CD56-dim; natural killer cell & CD56-dim, NKG2D+; natural killer cell & CD56-bright"	""	""	"18"	"55"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD40/CD86+ plasma dendritic cells (pDCs); CD86+ myeloid dendritic cells (mDCs); CD86+ CD16+ inflammatory monocytes; CD40/CD86+ monocytes; CD16+ inflammatory monocytes; CD38+ CD56dim natural killer (NK) cells; NKG2D+ CD56dim natural killer (NK) cells; CD56bright natural killer (NK) cells"	"cell type frequency"	"up"	"3d vs 0d"	"time of vaccination (first dose)"	"3"	"days"	"rVSV-EBOV"	"VO:0004660"	""	"ebola virus"	""	""	""	""	"28854372"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/"	"Fig 2A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/figure/fig2/"	""	"CL:0000784"	"PR:P29965, PR:000001412 "	"8"	"8"	"4"	"25"	"28854372_4_25"
""	"T cell & IFNG+"	""	""	"14"	"26"	"months"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"interferon-gamma-positive T cells"	"cell type frequency"	"up"	"28d (postboost) vs 0d (pre-imm)"	"time of vaccination (second dose)"	"28"	"days"	"Imuvac"	"VO:0003144"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Victoria/361/2011(H3N2)); influenza B virus (B/Wisconsin/01/2010)"	"2012"	""	""	""	"26755593"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/"	"Fig 2B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/figure/fig02/"	""	"CL:0000084"	"PR:000000017"	"1"	"1"	"1"	"26"	"26755593_1_26"
""	"T cell & IFNG+"	""	""	"14"	"26"	"months"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"interferon-gamma-positive T cells"	"cell type frequency"	"up"	"28d (postboost) vs 0d (pre-imm)"	"time of vaccination (second dose)"	"28"	"days"	"Fluad"	"VO:0004281"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Victoria/361/2011(H3N2)); influenza B virus (B/Wisconsin/01/2010)"	"2012"	""	""	""	"26755593"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/"	"Fig 2B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/figure/fig02/"	""	"CL:0000084"	"PR:000000017"	"1"	"1"	"2"	"27"	"26755593_2_27"
""	"effector memory CD4-positive, alpha-beta T cell & TNF-a, IL-2+; effector memory CD4-positive, alpha-beta T cell & IFNG-, TNF-a+, IL-2+"	""	""	"14"	"27"	"months"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"intereferon-gamma-positive, tumor-necrosis-factor-alfa-positive, interleukin-2-positive, effector memory CD4-positive, alpha-beta T cell; intereferon-gamma-negative, tumor-necrosis-factor-alfa-positive, interleukin-2-positive, effector memory CD4-positive, alpha-beta T cell"	"cell type frequency"	"up"	"28d (postboost) vs 0d (pre-imm)"	"time of vaccination (second dose)"	"28"	"days"	"Fluad"	"VO:0004281"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Victoria/361/2011(H3N2)); influenza B virus (B/Wisconsin/01/2010)"	"2012"	""	""	""	"26755593"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/"	"Fig 2A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/figure/fig02/"	""	"CL:0000905"	"PR:000000134, PR:000001379"	"2"	"2"	"3"	"28"	"26755593_3_28"
""	"B cell; CD4-positive, alpha-beta T cell; CD16-positive, CD56-dim natural killer cell, human; CD8-positive, alpha-beta T cell; granulocyte; lymphocyte"	""	""	"20"	"50"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"B cell; CD4+ alpha-beta T cell; CD16+ CD56dim natural killer cell; CD8+ alpha-beta T cell; granulocyte; lymphocyte"	"cell type frequency"	"down"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"days"	"MRKAd5/HIV"	"VO:0003133"	""	"human immunodeficiency virus 1"	""	""	""	""	"23151505"	"2012"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/"	"Fig. 1E"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/figure/fig01/"	""	"CL:0000236"	""	"6"	"6"	"1"	"29"	"23151505_1_29"
""	"CD14-positive, CD16-negative classical monocyte"	""	""	"20"	"50"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD14+ CD16- classical monocyte"	"cell type frequency"	"up"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"days"	"MRKAd5/HIV"	"VO:0003133"	""	"human immunodeficiency virus 1"	""	""	""	""	"23151505"	"2012"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/"	"Fig. 1E"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/figure/fig01/"	""	"CL:0002057"	""	"1"	"1"	"2"	"30"	"23151505_2_30"
""	"CD14-positive, CD16-negative classical monocyte; CD16-positive, CD56-dim natural killer cell, human"	""	""	"20"	"50"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD14+ CD16- classical monocyte; CD16+ CD56-dim natural killer cell"	"cell type frequency"	"up"	"3d vs 0d"	"time of vaccination (first dose)"	"3"	"days"	"MRKAd5/HIV"	"VO:0003133"	""	"human immunodeficiency virus 1"	""	""	""	""	"23151505"	"2012"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/"	"Fig. 1E"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/figure/fig01/"	""	"CL:0002057"	""	"2"	"2"	"3"	"31"	"23151505_3_31"
""	"B cell"	""	""	"20"	"50"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"B cell"	"cell type frequency"	"down"	"3d vs 0d"	"time of vaccination (first dose)"	"3"	"days"	"MRKAd5/HIV"	"VO:0003133"	""	"human immunodeficiency virus 1"	""	""	""	""	"23151505"	"2012"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/"	"Fig. 1E"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/figure/fig01/"	""	"CL:0000236"	""	"1"	"1"	"4"	"32"	"23151505_4_32"
""	"CD4-positive, CD25-positive, alpha-beta regulatory T cell"	""	"subgroup low responders"	"18"	"55"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD4-positive, CD25-positive, alpha-beta regulatory T cell"	"cell type frequency"	"up"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Modified Vaccinia Ankara (MVA) virus vaccine vector"	"VO:0003120"	""	"mycobacterium tuberculosis variant bovis BCG"	""	""	""	""	"23844129"	"2013"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23844129"	"Fig 2b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700883/figure/pone-0067922-g002/"	""	"CL:0000792"	""	"1"	"1"	"1"	"33"	"23844129_1_33"
""	"plasma cell"	""	""	"30"	"70"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"plasma cell"	"cell type frequency"	"positively correlated"	"MenC SBA at day 28"	"time of vaccination (first dose)"	"7"	"days"	"Menveo; ACWYVax"	"VO:0001246; VO:0003138"	""	"neisseria meningitidis"	""	""	""	""	"28137280"	"2017"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=28137280"	"Table 2"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282650/table/Tab2/"	""	"CL:0000786"	""	"1"	"1"	"1"	"34"	"28137280_1_34"
""	"T cell & IFNG+"	""	""	"50"	"75"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"IFN-gamma+ antigen specific T cell"	"cell type frequency"	"up"	"8d vs 0d"	"time of vaccination (first dose)"	"8"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/"	"Fig 1a, text"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g001/"	""	"CL:0000084"	"PR:000000017"	"1"	"1"	"1"	"35"	"27764254_1_35"
""	"T cell & IFNG+"	""	""	"50"	"75"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"IFN-gamma+ antigen specific T cell"	"cell type frequency"	"up"	"14d vs 0d"	"time of vaccination (first dose)"	"14"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/"	"Fig 1a, text"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g001/"	""	"CL:0000084"	"PR:000000017"	"1"	"1"	"2"	"36"	"27764254_2_36"
""	"T cell & IFNG+"	""	""	"50"	"75"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"IFN-gamma+ antigen specific T cell"	"cell type frequency"	"up"	"28d vs 0d"	"time of vaccination (first dose)"	"28"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/"	"Fig 1a, text"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g001/"	""	"CL:0000084"	"PR:000000017"	"1"	"1"	"3"	"37"	"27764254_3_37"
""	"T cell & IFNG+"	""	""	"50"	"75"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"IFN-gamma+ antigen specific T cell"	"cell type frequency"	"down"	"28d vs 8d"	"time of vaccination (first dose)"	"28"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/"	"Fig 1a, text"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g001/"	""	"CL:0000084"	"PR:000000017"	"1"	"1"	"4"	"38"	"27764254_4_38"
""	"CD4-positive, alpha-beta T cell & CD38+, HLA-DR+, VZV tetramer+"	""	""	"50"	"75"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD38+HLADR+ VZV tetramer+ cells (% of VZV tetramer CD4 T cells)"	"cell type frequency"	"up"	"8d vs 0d"	"time of vaccination (first dose)"	"8"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/"	"Fig 6b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g006/"	""	"CL:0000624"	"PR:000001408"	"1"	"1"	"5"	"39"	"27764254_5_39"
""	"CD4-positive, alpha-beta T cell & CD38+, HLA-DR+, VZV tetramer+"	""	""	"50"	"75"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD38+ HLADR+ VZV tetramer+ cells (% of VZV tetramer CD4 T cells)"	"cell type frequency"	"up"	"14d vs 0d"	"time of vaccination (first dose)"	"14"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"27764254"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/"	"Fig 6b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g006/"	""	"CL:0000624"	"PR:000001408"	"1"	"1"	"6"	"40"	"27764254_6_40"
""	"CD4-positive, alpha-beta T cell & IFNG+"	""	""	"18"	"55"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"interferon-gamma+ CD4 T cells"	"cell type frequency"	"up"	"29d vs 0d"	"time of vaccination (first dose)"	"29"	"days"	"VPM1002"	"VO:0003131"	""	"mycobacterium tuberculosis variant bovis BCG"	""	""	""	""	"23290835"	"2013"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23290835"	"Fig 3A"	"https://www.sciencedirect.com/science/article/pii/S0264410X12018403?via%3Dihub#fig0015"	""	"CL:0000624"	"PR:000000017"	"1"	"1"	"1"	"41"	"23290835_1_41"
""	"CD4-positive, alpha-beta T cell & IFNG+, TNF-a+, IL-2+"	""	""	"18"	"55"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"triple-positive (interferon-gamma, tumor necrosis factor-alpha, interleukin-2) CD4 T cells"	"cell type frequency"	"up"	"VPM1002-3 vs BCG vaccine"	"time of vaccination (first dose)"	"29"	"days"	"BCG vaccine; VPM1002"	"VO:0000771; VO:0003131"	""	"mycobacterium tuberculosis variant bovis BCG"	""	""	""	""	"23290835"	"2013"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23290835"	"Fig 3B"	"https://www.sciencedirect.com/science/article/pii/S0264410X12018403?via%3Dihub#fig0015"	""	"CL:0000624"	"PR:000000017, PR:000000134, PR:000001379"	"1"	"1"	"2"	"42"	"23290835_2_42"
""	"CD8-positive, alpha-beta T cell & IL17A+"	""	"infants"	""	""	""	""	"blood"	"UBERON:0000178"	"CD8+ interleukin-17+ (IL-17+) cells"	"cell type frequency"	"up"	"14d vs 0d"	"time of vaccination (first dose)"	"14"	"days"	"BCG vaccine; VPM1002"	"VO:0000771; VO:0003131"	""	"mycobacterium tuberculosis variant bovis BCG"	""	""	""	""	"27974398"	"2017"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27974398"	"Fig 4B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299117/figure/F4/"	""	"CL:0000625"	"PR:000001138"	"1"	"1"	"1"	"43"	"27974398_1_43"
""	"CD8-positive, alpha-beta T cell & IL17A+"	""	"infants"	""	""	""	""	"blood"	"UBERON:0000178"	"CD8+ interleukin-17+ (IL-17+) cells"	"cell type frequency"	"up"	"6m vs 0m"	"time of vaccination (first dose)"	"6"	"months"	"BCG vaccine; VPM1002"	"VO:0000771; VO:0003131"	""	"mycobacterium tuberculosis variant bovis BCG"	""	""	""	""	"27974398"	"2017"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27974398"	"Fig 4B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299117/figure/F4/"	""	"CL:0000625"	"PR:000001138"	"1"	"1"	"2"	"44"	"27974398_2_44"
""	"leukocyte; neutrophil; lymphocyte; eosinophil"	""	""	"18"	"40"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"white blood cell; neutrophil; lymphocyte; eosinophil"	"cell type frequency"	"down"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"YF-VAX"	"VO:0000121"	""	"yellow fever virus 17D"	""	""	""	""	"17651872"	"2007"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=17651872"	"Text: Study Summaries and Clinical Observations"	""	""	"CL:0000738"	""	"4"	"4"	"1"	"45"	"17651872_1_45"
""	"IgG memory B cell & CD3-, CD19+, CD27+, HLADR+, IgG+; IgG memory B cell & CD3-, CD19+, CD27+, CD10-, CD20+, HLADR+, IgG+"	""	""	"65"	"83"	"years"	""	"blood"	"UBERON:0000178"	"switched IgG+ memory B cells (CD3-, CD19+, HLADR+, CD27+, IgG+); IgG+ memory B cells (CD3-, CD19+, HLADR+, CD27+, CD10-, CD20+, IgG+)"	"cell type frequency"	"positively predictive"	"anti-HBsAg ab titre"	"time of vaccination (first dose)"	"0"	"days"	"Twinrix"	"VO:0000113"	""	"hepatitis B virus"	""	""	""	""	"26742691"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=26742691"	"Fig 5b; Table 1"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729923/table/t1/"	"EM131 elderly cohort (65-83)"	"CL:0000979"	"PR:000001020, PR:000001002, PR:000001963"	"2"	"2"	"1"	"46"	"26742691_1_46"
""	"CD4-positive, alpha-beta T cell & TEM2+; plasmacytoid dendritic cell & CD40+"	""	""	"65"	"83"	"years"	""	"blood"	"UBERON:0000178"	"TEM2+ CD4+ T Cell; CD40+ pDC"	"cell type frequency"	"positively correlated"	"anti-HBsAg ab titre"	"time of vaccination (first dose)"	"0"	"days"	"Twinrix"	"VO:0000113"	""	"hepatitis B virus"	""	""	""	""	"26742691"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=26742691"	"Fig 5a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729923/figure/f5"	"EM131 elderly cohort (65-83)"	"CL:0000624"	"PR:Q96D21 "	"2"	"2"	"2"	"47"	"26742691_2_47"
""	"memory B cell"	""	""	"50"	"74"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"memory B cell"	"cell type frequency"	"up"	"28d vs 0d"	"time of vaccination (first dose)"	"28"	"days"	"Fluarix"	"VO:0000045"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"27317456"	"2016"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27317456"	"Text: Subjects Demographics and Memory B cell ELISPOT response"	""	""	"CL:0000787"	""	"1"	"1"	"1"	"48"	"27317456_1_48"
""	"IgG plasmablast"	""	"adults"	""	""	""	""	"peripheral blood mononuclear cell"	"CL:2000001"	"IgG+ Antibody secreting cells"	"cell type frequency"	"up"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Fluvirin; Pandemrix"	"VO:0000046; VO:0000410"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009, pan"	""	""	""	"24725414"	"2014"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"Fig 3a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F3/"	""	"CL:0000982"	""	"1"	"1"	"1"	"49"	"24725414_1_49"
""	"monocyte & CD40+; CD8-positive, alpha-beta T cell & CD38+; monocyte & CD86+; naive B cell & CD86+; CD8-positive, alpha-beta T cell & CD69+; CD8-positive, CD25-positive, alpha-beta regulatory T cell; memory B cell & CD27+, CD38+, IgD+; CD4-positive, alpha-beta T cell & IL-2+; CD4-positive, alpha-beta T cell & HLA-DR+; CD4-positive, alpha-beta T cell & CD103+; CD14-positive monocyte & CD45+, viable; IgD-negative memory B cell & CD80+, CD27+; CD8-positive, alpha-beta T cell & CD103+; dendritic cell & interferon alpha+; CD8-positive, alpha-beta T cell & HLA-DR+; CD4-positive, alpha-beta T cell & IL-4+"	""	"adults"	""	""	""	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD40+ monocytes; CD38+ of CD8+ T cells; CD86+ monocytes; CD86+ of naive B cells; CD69+ of CD8+ T cells; CD25+ of CD8+ Tcells; CD38+ of IgD+CD27+ memory B cells; IL2+ of CD4+ T cells; HLA-DR+ of CD4+ T cells; CD103+ of CD4+ T cells; CD14+ of viable CD45+ cells (Total monocytes); CD80+ of IgD-CD27+ memory B cells; CD103+ of CD8+ T cells; IFNa+ of pDCs; HLA-DR+ of CD8+ T cells; IL4+ of CD4+ T cells"	"cell type frequency"	"up"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"days"	"Fluvirin; Pandemrix"	"VO:0000046; VO:0000410"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009, pan"	""	""	""	"24725414"	"2014"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"Fig 3d"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F3/"	""	"CL:0000576"	"PR:000001961"	"16"	"16"	"2"	"50"	"24725414_2_50"
""	"plasmablast & CD21+; IgA memory B cell & CD27+, IgD-"	""	"adults"	""	""	""	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD21+ plasmablast; IgA+ of IgD-CD27+ memory B cells"	"cell type frequency"	"down"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Fluvirin; Pandemrix"	"VO:0000046; VO:0000410"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009, pan"	""	""	""	"24725414"	"2014"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"Fig 3d"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F3/"	""	"CL:0000980"	"PR:000001338"	"2"	"2"	"3"	"51"	"24725414_3_51"
""	"plasmablast & CD27-hi, CD38-hi, CD20-; IgD-negative memory B cell & CD27+, CD38+; B cell & CD20+, CD86+; CD4-positive, alpha-beta T cell & CD38+; naive B cell & CD86+; CD4-positive, alpha-beta T cell & IL-4+; CD8-positive, alpha-beta T cell & CD39+; IgD-negative memory B cell & CD86+, CD27-"	""	"adults"	""	""	""	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD27hi CD38hi of CD20- B cells (plasmablasts); CD38+ of IgD-CD27+ memory B cells; CD86+ of CD20+ B cells; CD38+ of CD4+ T cells; CD86+ of Naive B Cells; IL4+ of CD4+ T cells; CD39+ of CD8+ T cells; CD86+ of IgD-CD27- memory B cells"	"cell type frequency"	"up"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Fluvirin; Pandemrix"	"VO:0000046; VO:0000410"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009, pan"	""	""	""	"24725414"	"2014"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"Fig 3d"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F3/"	""	"CL:0000980"	"PR:000001963, PR:000001408, PR:000001289"	"8"	"8"	"4"	"52"	"24725414_4_52"
""	"plasmablast"	""	"adults"	""	""	""	""	"peripheral blood mononuclear cell"	"CL:2000001"	"plasmablast"	"cell type frequency"	"up"	"low baseline titer group vs high baseline titer group"	"time of vaccination (first dose)"	"7"	"days"	"Fluvirin; Pandemrix"	"VO:0000046; VO:0000410"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009, pan"	""	""	""	"24725414"	"2014"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"Fig 4c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F4/"	""	"CL:0000980"	""	"1"	"1"	"5"	"53"	"24725414_5_53"
""	"CD4-positive, alpha-beta T cell & IL22+, CD161-; CD4-positive, alpha-beta T cell & IL-2+; transitional stage B cell & CD38+; B cell & CD20+, CD27+, CD38+, IgD-; memory B cell & CD27+, CD38+, IgD+; naive B cell & CD38+"	""	"adults"	""	""	""	""	"peripheral blood mononuclear cell"	"CL:2000001"	"IL22+ of CD161- CD4+ T cells; IL2+ of CD4+ T cells; CD38+ of transitional B cells; CD38+ of CD20+IgD-CD27+ B cells; CD38+ of IgD+CD27+ memory B cells; CD38+ of Naive B cells"	"cell type frequency"	"positively predictive"	"d28 HAI"	"time of vaccination (first dose)"	"0"	"days"	"Fluvirin; Pandemrix"	"VO:0000046; VO:0000410"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009, pan"	""	""	""	"24725414"	"2014"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"Fig 6c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F6/"	""	"CL:0000624"	"PR:000001383, PR:000025670 "	"6"	"6"	"6"	"54"	"24725414_6_54"
""	"CD4-positive, alpha-beta memory T cell & CD27+, CCR7-"	""	"adults"	""	""	""	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD27+CCR7- of memory CD4+ T cells"	"cell type frequency"	"negatively predictive"	"d28 HAI"	"time of vaccination (first dose)"	"0"	"days"	"Fluvirin; Pandemrix"	"VO:0000046; VO:0000410"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Brisbane/60/2008); influenza A virus (A/California/7/2009(H1N1))"	"2009, pan"	""	""	""	"24725414"	"2014"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/"	"Fig 6c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F6/"	""	"CL:0000897"	"PR:000001963, PR:000001203 "	"1"	"1"	"7"	"55"	"24725414_7_55"
""	"IgG plasmablast & influenza-specific"	""	""	"18"	"50"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"influenza-specific IgG secreting plasmablasts"	"cell type frequency"	"positively correlated"	"HAI response at 28 days"	"time of vaccination (first dose)"	"7"	"days"	"Fluarix; Fluvirin"	"VO:0000045; VO:0000046"	""	"influenza A virus (A/Solomon Islands/3/2006(H1N1)); influenza A virus (A/Wisconsin/67/2005(H3N2)); influenza B virus (B/Malaysia/2506/2004); influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006); influenza B virus (B/Brisbane/60/2008)"	"2007, 2008, 2009"	""	""	""	"21743478"	"2011"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/"	"Fig 1e"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/figure/F1/"	""	"CL:0000982"	""	"1"	"1"	"1"	"56"	"21743478_1_56"
""	"IgM plasmablast & influenza-specific"	""	""	"18"	"50"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"influenza-specific IgM secreting plasmablasts"	"cell type frequency"	"positively correlated"	"HAI response at 28 days"	"time of vaccination (first dose)"	"7"	"days"	"Fluarix; Fluvirin"	"VO:0000045; VO:0000046"	""	"influenza A virus (A/Solomon Islands/3/2006(H1N1)); influenza A virus (A/Wisconsin/67/2005(H3N2)); influenza B virus (B/Malaysia/2506/2004); influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006); influenza B virus (B/Brisbane/60/2008)"	"2007, 2008, 2009"	""	""	""	"21743478"	"2011"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/"	"Supp Fig 1b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/#SD1"	""	"CL:0000983"	""	"1"	"1"	"2"	"57"	"21743478_2_57"
""	"IgA plasmablast & influenza-specific"	""	""	"18"	"50"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"influenza-specific IgA secreting plasmablasts"	"cell type frequency"	"positively correlated"	"HAI response at 28 days"	"time of vaccination (first dose)"	"7"	"days"	"Fluarix; Fluvirin"	"VO:0000045; VO:0000046"	""	"influenza A virus (A/Solomon Islands/3/2006(H1N1)); influenza A virus (A/Wisconsin/67/2005(H3N2)); influenza B virus (B/Malaysia/2506/2004); influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006); influenza B virus (B/Brisbane/60/2008)"	"2007, 2008, 2009"	""	""	""	"21743478"	"2011"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/"	"Supp Fig 1b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/#SD1"	""	"CL:0000984"	""	"1"	"1"	"3"	"58"	"21743478_3_58"
""	"IgG plasmablast & influenza-specific"	""	""	"18"	"50"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"influenza-specific IgG secreting plasmablasts"	"cell type frequency"	"positively correlated"	"total plasmablast"	"time of vaccination (first dose)"	"7"	"days"	"Fluarix; Fluvirin"	"VO:0000045; VO:0000046"	""	"influenza A virus (A/Solomon Islands/3/2006(H1N1)); influenza A virus (A/Wisconsin/67/2005(H3N2)); influenza B virus (B/Malaysia/2506/2004); influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006); influenza B virus (B/Brisbane/60/2008)"	"2007, 2008, 2009"	""	""	""	"21743478"	"2011"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/"	"Fig 1d"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/figure/F1/"	""	"CL:0000982"	""	"1"	"1"	"4"	"59"	"21743478_4_59"
""	"IgG plasmablast & influenza-specific"	""	""	"18"	"50"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"influenza-specific IgG secreting plasmablasts"	"cell type frequency"	"positively correlated"	"total plasmablast"	"time of vaccination (first dose)"	"7"	"days"	"FluMist"	"VO:0000044"	""	"influenza A virus (A/Brisbane/59/2007(H1N1)); influenza A virus (A/Brisbane/10/2007(H3N2)); influenza B virus (B/Florida/4/2006)"	"2008"	""	""	""	"21743478"	"2011"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/"	"Fig 1d"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/figure/F1/"	""	"CL:0000982"	""	"1"	"1"	"5"	"60"	"21743478_5_60"
""	"naive B cell & CD19+, CD27-, IgD-; IgD-negative memory B cell & CD19+, CD27+; transitional stage B cell & CD19+, CD24+, CD38+"	""	"subgroup LAIV"	"0.5"	"14"	"years"	"29"	"blood"	"UBERON:0000178"	"naive B cells (CD19-positive, IgD-negative, CD27-negative) (CL_0000788); memory B cells (CD19+, IgD-, CD27+) (CL_0001053); transitional B cells (CD19+, CD24+, CD38+) (CL_0000818)"	"cell type frequency"	"up"	"30d vs 0d"	"time of vaccination (first dose)"	"27 to 33"	"days"	"Fluzone"	"VO:0000047"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"24495909"	"2014"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/"	"Fig 1"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F1/"	""	"CL:0000788"	"PR:000001002, PR:000001963"	"3"	"3"	"1"	"61"	"24495909_1_61"
""	"plasmablast & CD19+, CD27+, CD38+"	""	"subgroup TIV"	"0.5"	"14"	"years"	"29"	"blood"	"UBERON:0000178"	"plasmablasts (CD19+, CD27+, CD38+)"	"cell type frequency"	"up"	"7d vs 0d"	"time of vaccination (first dose)"	"6 to 8"	"days"	"Fluzone"	"VO:0000047"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"24495909"	"2014"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/"	"Fig 1"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F1/"	""	"CL:0000980"	"PR:000001002, PR:000001963, PR:000001408"	"1"	"1"	"2"	"62"	"24495909_2_62"
""	"plasmablast; plasma cell"	""	"subgroup TIV"	"0.5"	"14"	"years"	"29"	"blood"	"UBERON:0000178"	"plasmablast; plasma cell"	"cell type frequency"	"positively correlated"	"HI titers to H3N2 and B strains at 30 days"	"time of vaccination (first dose)"	"6 to 8"	"days"	"Fluzone"	"VO:0000047"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"24495909"	"2014"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/"	"Fig 2A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F2/"	""	"CL:0000980"	""	"2"	"2"	"3"	"63"	"24495909_3_63"
""	"plasmablast"	""	"subgroup TIV"	"0.5"	"14"	"years"	"29"	"blood"	"UBERON:0000178"	"plasmablast"	"cell type frequency"	"positively correlated"	"VN titer to B strain at 30 days"	"time of vaccination (first dose)"	"6 to 8"	"days"	"Fluzone"	"VO:0000047"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"24495909"	"2014"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/"	"Fig 2B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F2/"	""	"CL:0000980"	""	"1"	"1"	"4"	"64"	"24495909_4_64"
""	"plasma cell"	""	"subgroup TIV"	"0.5"	"14"	"years"	"29"	"blood"	"UBERON:0000178"	"plasma cell"	"cell type frequency"	"positively correlated"	"VN titer to H1N1, H3N2, B strains at 30 days"	"time of vaccination (first dose)"	"6 to 8"	"days"	"Fluzone"	"VO:0000047"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"24495909"	"2014"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/"	"Fig 2B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F2/"	""	"CL:0000786"	""	"1"	"1"	"5"	"65"	"24495909_5_65"
""	"plasmablast"	""	"subgroup LAIV"	"0.5"	"14"	"years"	"29"	"blood"	"UBERON:0000178"	"plasmablast"	"cell type frequency"	"positively correlated"	"H3N2 VN titer at 30 days"	"time of vaccination (first dose)"	"6 to 8"	"days"	"FluMist"	"VO:0000044"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"24495909"	"2014"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/"	"(Fig 2B) Text: Antibody-Secreting Cells Correlate With Antibody Titers on TIV Recipients"	""	""	"CL:0000980"	""	"1"	"1"	"6"	"66"	"24495909_6_66"
""	"natural killer cell"	""	"young (<65 yo), elderly (>65 yo)"	""	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"natural killer cell"	"cell type frequency"	"up"	"young adults vs old adults"	"time of vaccination (first dose)"	"0"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000623"	""	"1"	"1"	"1"	"67"	"26682988_1_67"
""	"CD16-positive, CD56-dim natural killer cell, human & CD16++"	""	"young (<65 yo), elderly (>65 yo)"	""	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD56dim CD16++ natural killer cells"	"cell type frequency"	"up"	"seniors vs adults"	"time of vaccination (first dose)"	"0"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	"5A is comparisions within group against baseline"	"CL:0000939"	"PR:000001483"	"1"	"1"	"2"	"68"	"26682988_2_68"
""	"natural killer cell & CD56-bright; natural killer cell & CD56++, CD16+"	""	"young (<65 yo), elderly (>65 yo)"	""	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD56++ natural killer cells; CD56++ CD16+ Natural Killer cells"	"cell type frequency"	"up"	"adults vs seniors"	"time of vaccination (first dose)"	"0"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000623"	"PR:000001024"	"2"	"2"	"3"	"69"	"26682988_3_69"
""	"natural killer cell"	""	"young (<65 yo), elderly (>65 yo)"	""	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"natural killer cell"	"cell type frequency"	"up"	"seniors vs adults"	"time of vaccination (first dose)"	"1"	"day"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000623"	""	"1"	"1"	"4"	"70"	"26682988_4_70"
""	"natural killer cell"	""	"young (<65 yo), elderly (>65 yo)"	""	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"natural killer cell"	"cell type frequency"	"up"	"seniors vs adults"	"time of vaccination (first dose)"	"3"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000623"	""	"1"	"1"	"5"	"71"	"26682988_5_71"
""	"natural killer cell"	""	"young (<65 yo), elderly (>65 yo)"	""	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"natural killer cell"	"cell type frequency"	"up"	"seniors vs adults"	"time of vaccination (first dose)"	"7"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000623"	""	"1"	"1"	"6"	"72"	"26682988_6_72"
""	"natural killer cell"	""	"young (<65 yo), elderly (>65 yo)"	""	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"natural killer cell"	"cell type frequency"	"up"	"seniors vs adults"	"time of vaccination (first dose)"	"14"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000623"	""	"1"	"1"	"7"	"73"	"26682988_7_73"
""	"natural killer cell"	""	""	"65"	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"natural killer cell"	"cell type frequency"	"up"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000623"	""	"1"	"1"	"8"	"74"	"26682988_8_74"
""	"natural killer cell"	""	""	"65"	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"natural killer cell"	"cell type frequency"	"up"	"3d vs 0d"	"time of vaccination (first dose)"	"3"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000623"	""	"1"	"1"	"9"	"75"	"26682988_9_75"
""	"natural killer cell"	""	""	"65"	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"natural killer cell"	"cell type frequency"	"up"	"14d vs 0d"	"time of vaccination (first dose)"	"14"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000623"	""	"1"	"1"	"10"	"76"	"26682988_10_76"
""	"natural killer cell"	""	"adults"	""	"65"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"natural killer cell"	"cell type frequency"	"down"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000623"	""	"1"	"1"	"11"	"77"	"26682988_11_77"
""	"natural killer cell & CD56++; natural killer cell & CD56++, CD16+"	""	"adults"	""	"65"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD56++ NK cells; CD56++ CD16+ NK cells"	"cell type frequency"	"up"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000623"	"PR:000001024"	"2"	"2"	"12"	"78"	"26682988_12_78"
""	"CD16-positive, CD56-dim natural killer cell, human & CD16++; natural killer cell"	""	""	"65"	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD56dim CD16++ NK cells; Natural Killer cells"	"cell type frequency"	"up"	"1 vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5A&C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000939"	"PR:000001483"	"2"	"2"	"13"	"79"	"26682988_13_79"
""	"natural killer cell & CD56++; natural killer cell & CD56++, CD16+"	""	""	"65"	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD56++ NK cells; CD56++ CD16+ NK cells"	"cell type frequency"	"down"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000623"	"PR:000001024"	"2"	"2"	"14"	"80"	"26682988_14_80"
""	"monocyte"	""	"adults"	""	"65"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"monocytes"	"cell type frequency"	"up"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0000576"	""	"1"	"1"	"15"	"81"	"26682988_15_81"
""	"monocyte"	""	""	"65"	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"monocytes"	"cell type frequency"	"up"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0000576"	""	"1"	"1"	"16"	"82"	"26682988_16_82"
""	"monocyte"	""	"adults"	""	"65"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"monocytes"	"cell type frequency"	"down"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0000576"	""	"1"	"1"	"17"	"83"	"26682988_17_83"
""	"monocyte"	""	""	"65"	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"monocytes"	"cell type frequency"	"down"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0000576"	""	"1"	"1"	"18"	"84"	"26682988_18_84"
""	"monocyte"	""	"young (<65 yo), elderly (>65 yo)"	""	""	""	""	"peripheral blood mononuclear cell"	"CL:2000001"	"monocytes"	"cell type frequency"	"up"	"seniors vs adults"	"time of vaccination (first dose)"	"0"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0000576"	""	"1"	"1"	"19"	"85"	"26682988_19_85"
""	"monocyte"	""	"young (<65 yo), elderly (>65 yo)"	""	""	""	""	"peripheral blood mononuclear cell"	"CL:2000001"	"monocytes"	"cell type frequency"	"up"	"seniors vs adults"	"time of vaccination (first dose)"	"1"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0000576"	""	"1"	"1"	"20"	"86"	"26682988_20_86"
""	"monocyte"	""	"young (<65 yo), elderly (>65 yo)"	""	""	""	""	"peripheral blood mononuclear cell"	"CL:2000001"	"monocytes"	"cell type frequency"	"up"	"seniors vs adults"	"time of vaccination (first dose)"	"3"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0000576"	""	"1"	"1"	"21"	"87"	"26682988_21_87"
""	"monocyte"	""	"young (<65 yo), elderly (>65 yo)"	""	""	""	""	"peripheral blood mononuclear cell"	"CL:2000001"	"monocytes"	"cell type frequency"	"up"	"seniors vs adults"	"time of vaccination (first dose)"	"7"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0000576"	""	"1"	"1"	"22"	"88"	"26682988_22_88"
""	"monocyte"	""	"young (<65 yo), elderly (>65 yo)"	""	""	""	""	"peripheral blood mononuclear cell"	"CL:2000001"	"monocytes"	"cell type frequency"	"up"	"seniors vs adults"	"time of vaccination (first dose)"	"14"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0000576"	""	"1"	"1"	"23"	"89"	"26682988_23_89"
""	"CD14-positive, CD16-negative classical monocyte"	""	""	""	"65"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD14+ CD16- monocytes"	"cell type frequency"	"down"	"3d vs 0d"	"time of vaccination (first dose)"	"3"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0002057"	""	"1"	"1"	"24"	"90"	"26682988_24_90"
""	"CD14-positive, CD16-positive monocyte"	""	""	""	"65"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD14+ CD16+ monocytes"	"cell type frequency"	"up"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0002397"	""	"1"	"1"	"25"	"91"	"26682988_25_91"
""	"natural killer cell & CD56++, CD16+"	""	""	""	"65"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD56++ CD16+ natural killer (NK) cells"	"cell type frequency"	"up"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/"	""	"CL:0000623"	"PR:000001024, PR:000001483"	"1"	"1"	"26"	"92"	"26682988_26_92"
""	"CD14-low, CD16-positive monocyte & CD14-dim, CD16++"	""	""	""	"65"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD14dim CD16++ monocytes"	"cell type frequency"	"up"	"3d vs 0d"	"time of vaccination (first dose)"	"3"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0002396"	"PR:000001889, PR:000001483"	"1"	"1"	"27"	"93"	"26682988_27_93"
""	"CD14-positive, CD16-negative classical monocyte"	""	""	"65"	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD14+ CD16- monocytes"	"cell type frequency"	"up"	"14d vs 0d"	"time of vaccination (first dose)"	"14"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0002057"	""	"1"	"1"	"28"	"94"	"26682988_28_94"
""	"CD14-positive, CD16-positive monocyte"	""	""	"65"	""	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD14+ CD16+ monocytes"	"cell type frequency"	"down"	"14d vs 0d"	"time of vaccination (first dose)"	"14"	"days"	"Inactivated influenza vaccine"	"VO:0001176"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"26682988"	"2015"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/"	"Fig S6B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title"	""	"CL:0002397"	""	"1"	"1"	"29"	"95"	"26682988_29_95"
""	"activated CD4-positive, alpha-beta T cell"	""	"adults, seniors (25-40/60-79)"	"25"	"79"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"activated CD4+ T cells"	"cell type frequency"	"down"	"high vs low inositol phosphate metabolism"	"time of vaccination (first dose)"	"7"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"28502771"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711477/"	"Fig 7F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711477/figure/F7/"	""	"CL:0000896"	""	"1"	"1"	"1"	"96"	"28502771_1_96"
""	"neutrophil"	""	"adults, seniors (25-40/60-79)"	"25"	"79"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"neutrophil"	"cell type frequency"	"down"	"high vs low inositol phosphate metabolism"	"time of vaccination (first dose)"	"3"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"28502771"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711477/"	"Fig 7F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711477/figure/F7/"	""	"CL:0000775"	""	"1"	"1"	"2"	"97"	"28502771_2_97"
""	"CD4-positive, alpha-beta T cell & VZV antigen-reactive"	""	""	"52"	"75"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"VZV antigen-reactive CD4 T cells"	"cell type frequency"	"up"	"8d vs 0d"	"time of vaccination (first dose)"	"8"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"27030598"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/"	"text right before Fig 3, Fig 3a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/figure/F3/"	"Influence of vaccination on the CD4 T cell receptor repertoire of VZV-reactive cells"	"CL:0000624"	""	"1"	"1"	"1"	"98"	"27030598_1_98"
""	"CD4-positive, alpha-beta T cell & VZV antigen-reactive"	""	""	"52"	"75"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"VZV antigen-reactive CD4 T cells"	"cell type frequency"	"up"	"14d vs 0d"	"time of vaccination (first dose)"	"14"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"27030598"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/"	"text right before Fig 3, Fig 3a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/figure/F3/"	"Influence of vaccination on the CD4 T cell receptor repertoire of VZV-reactive cells"	"CL:0000624"	""	"1"	"1"	"2"	"99"	"27030598_2_99"
""	"CD4-positive, alpha-beta T cell & VZV antigen-reactive"	""	""	"52"	"75"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"VZV antigen-reactive CD4 T cells"	"cell type frequency"	"up"	"28d vs 0d"	"time of vaccination (first dose)"	"28"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"27030598"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/"	"text right before Fig 3, Fig 3a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/figure/F3/"	"Influence of vaccination on the CD4 T cell receptor repertoire of VZV-reactive cells"	"CL:0000624"	""	"1"	"1"	"3"	"100"	"27030598_3_100"
""	"leukocyte"	""	"infants (10 mo), subgoup males"	"4"	"11"	"months"	""	"blood"	"UBERON:0000178"	"white blood cell"	"cell type frequency"	"up"	"(MV + DTP) vs (MV and DTP separately)"	"time of vaccination (first dose)"	"28"	"days"	"Measles virus vaccine; Diphtheria-Tetanus-Pertussis vaccine"	"VO:0000654; VO:0000738"	""	"measles virus strain Edmonston-Zagreb; corynebacterium diphtheriae; clostridium tetani; human poliovirus 1; human poliovirus 2; human poliovirus 3"	""	""	""	""	"27436422"	"2016"	"https://academic.oup.com/cid/article/63/9/1213/2576500"	"Table 1"	"https://academic.oup.com/view-large/78928196"	""	"CL:0000738"	""	"1"	"1"	"1"	"101"	"27436422_1_101"
""	"lymphocyte"	""	"infants (10 mo), subgoup males"	"4"	"11"	"months"	""	"blood"	"UBERON:0000178"	"lymphocyte"	"cell type frequency"	"down"	"(MV + DTP) vs (MV and DTP separately)"	"time of vaccination (first dose)"	"28"	"days"	"Measles virus vaccine; Diphtheria-Tetanus-Pertussis vaccine"	"VO:0000654; VO:0000738"	""	"measles virus strain Edmonston-Zagreb; corynebacterium diphtheriae; clostridium tetani; human poliovirus 1; human poliovirus 2; human poliovirus 3"	""	""	""	""	"27436422"	"2016"	"https://academic.oup.com/cid/article/63/9/1213/2576500"	"Table 1"	"https://academic.oup.com/view-large/78928196"	""	"CL:0000542"	""	"1"	"1"	"2"	"102"	"27436422_2_102"
""	"plasmacytoid dendritic cell; natural killer cell & CD14-, CD19-, CD3-, CD107a+, K562 cells; natural killer cell & CD14-, CD19-, CD3-, IFNG+, K562 cells; natural killer cell & CD14-, CD19-, CD3-, TNF-a+, K562 cells"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"plasmacytoid dendritic cell; NK Cells (CD14-/CD19-/CD3-/NK/CD107A+/K562); NK Cells (CD14-/CD19-/CD3-/NK/IFNg+/K562); NK Cells (CD14-/CD19-/CD3-/NK/TNFa+/K562)"	"cell type frequency"	"up"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 4g-i"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/"	""	"CL:0000784"	""	"4"	"4"	"1"	"103"	"28687661_1_103"
""	"natural killer cell & CD14-, CD20-, CD3-; natural killer cell & CD14-, CD20-, CD3-, NKGA2+; natural killer cell & CD14-, CD20-, CD3-, NKG2-A/B-activating NK receptor+"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"NK cells (CD14-/CD20-/CD3-/NK); NK cells (CD14-/CD20-/CD3-/NK/NKG2A+); NK cells (CD14-/CD20-/CD3-/NK/NKP46+)"	"cell type frequency"	"down"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 4d-f"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/"	""	"CL:0000623"	"PR:000001889, PR:000001289, PR:000001020"	"3"	"3"	"2"	"104"	"28687661_2_104"
""	"B cell & CD3-, CD19+, CD20+, CD27+, IgD-, IgM-; CD4-positive, alpha-beta T cell & CD3+, CD28+; CD4-positive, alpha-beta T cell & CD3+, pKI-67+; CD8-positive, alpha-beta T cell & CD3+, CD28+; CD8-positive, alpha-beta T cell & CD3+, pKI-67+"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"B cells CD3-/CD19+CD20+/IgD-IgM-/CD27+; T cells CD3+/CD4+/CD28+; T cells CD3+/CD4+/Ki67+; T cells CD3+/CD8+/CD28+; T cells CD3+/CD8+/Ki67+"	"cell type frequency"	"down"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 5d-h"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	"CL:0000236"	"PR:000001020, PR:000001002, PR:000001289, PR:000001963"	"5"	"5"	"3"	"105"	"28687661_3_105"
""	"CD14-positive monocyte; natural killer cell & CD14-, CD20-, CD3-, NKG2-A/B-activating NK receptor+"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"Monocytes (CD14+); NK cells (CD14-/CD20-/CD3-/NK/NKP46+)"	"cell type frequency"	"down"	"14d vs 0d"	"time of vaccination (first dose)"	"14"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 4a, Fig 4f,"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/"	""	"CL:0001054"	""	"2"	"2"	"4"	"106"	"28687661_4_106"
""	"CD4-positive, alpha-beta T cell & CD3+, pKI-67+; CD8-positive, alpha-beta T cell & CD3+, pKI-67+"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"T cells CD3+/CD4+/Ki67+; T cells CD3+/CD8+/Ki67+"	"cell type frequency"	"down"	"14d vs 0d"	"time of vaccination (first dose)"	"14"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 5f, Fig 5h"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	"CL:0000624"	"PR:000001020, PR:000029630"	"2"	"2"	"5"	"107"	"28687661_5_107"
""	"plasmacytoid dendritic cell; B cell & CD3-, CD19+, CD20+; IgM memory B cell & CD3-, CD19+, CD20+, CD27+; CD4-positive, alpha-beta T cell & CD14-, CD3+, IL2+, ENV"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"plasmacytoid dendritic cell; B cells CD3-/CD19+CD20+; B cells CD3-/CD19+CD20+/IgD-IgM+/CD27+; T cells Cd14-/CD3+/CD4+/IL2+/ENV"	"cell type frequency"	"up"	"28d vs 0d"	"time of vaccination (first dose)"	"28"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"text (Vaccination with YF-17D induces...), Fig 4C, Fig 5A-B, Fig 5J"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	"CL:0000784"	""	"4"	"4"	"6"	"108"	"28687661_6_108"
""	"natural killer cell & CD14-, CD20-, CD3-; natural killer cell & CD14-, CD20-, CD3-, NKGA2+; natural killer cell & CD14-, CD20-, CD3-, NKG2-A/B-activating NK receptor+"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"NK cells (CD14-/CD20-/CD3-/NK); NK cells (CD14-/CD20-/CD3-/NK/NKG2A+); NK cells (CD14-/CD20-/CD3-/NK/NKP46+)"	"cell type frequency"	"down"	"28d vs 0d"	"time of vaccination (first dose)"	"28"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 4D-F"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/"	""	"CL:0000623"	"PR:000001889, PR:000001289, PR:000001020"	"3"	"3"	"7"	"109"	"28687661_7_109"
""	"CD4-positive, alpha-beta T cell & CD3+, CD28+; CD4-positive, alpha-beta T cell & CD3+, pKI-67+; CD8-positive, alpha-beta T cell & CD3+, pKI-67+"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"T cells CD3+/CD4+/CD28+; T cells CD3+/CD4+/Ki67+; T cells CD3+/CD8+/Ki67+"	"cell type frequency"	"down"	"28d vs 0d"	"time of vaccination (first dose)"	"28"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 5E-F, Fig 5H"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	"CL:0000624"	"PR:000001020, PR:000001841"	"3"	"3"	"8"	"110"	"28687661_8_110"
""	"dendritic cell & CD123+, NK-"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"DC (NK-/CD123)"	"cell type frequency"	"up"	"86d vs 0d"	"time of vaccination (first dose)"	"86"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 4C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/"	""	"CL:0000451"	"PR:000001865"	"1"	"1"	"9"	"111"	"28687661_9_111"
""	"B cell & CD3-, CD19+, CD20+; IgM memory B cell & CD3-, CD19+, CD20+, CD27+; B cell & CD3-, CD19+, CD20+, CD27+, IgD-, IgM-; CD4-positive, alpha-beta T cell & CD14-, CD3+, IL2+, NS1"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"B cells CD3-/CD19+CD20+; B cells CD3-/CD19+CD20+/IgD-IgM+/CD27+; B cells CD3-/CD19+CD20+/IgD-IgM-/CD27+; T cells CD14-/CD3+/CD4+/IL2+/NS1"	"cell type frequency"	"up"	"86d vs 0d"	"time of vaccination (first dose)"	"86"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 5A, 5C, 5D, 5I"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	"CL:0000236"	"PR:000001020, PR:000001002, PR:000001289"	"4"	"4"	"10"	"112"	"28687661_10_112"
""	"natural killer cell & CD14-, CD20-, CD3-; natural killer cell & CD14-, CD20-, CD3-, NKGA2+; natural killer cell & CD14-, CD20-, CD3-, NKG2-A/B-activating NK receptor+"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"NK cells (CD14-/CD20-/CD3-/NK); NK cells (CD14-/CD20-/CD3-/NK/NKG2A+); NK cells (CD14-/CD20-/CD3-/NK/NKP46+)"	"cell type frequency"	"down"	"86d vs 0d"	"time of vaccination (first dose)"	"86"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 4D, 4E, 4F,"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/"	""	"CL:0000623"	"PR:000001889, PR:000001289, PR:000001020"	"3"	"3"	"11"	"113"	"28687661_11_113"
""	"CD4-positive, alpha-beta T cell & CD3+, pKI-67+; CD8-positive, alpha-beta T cell & CD3+, pKI-67+"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"T cells CD3+/CD4+/Ki67+; T cells CD3+/CD8+/Ki67+"	"cell type frequency"	"down"	"86d vs 0d"	"time of vaccination (first dose)"	"86"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 5F, 5H"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	"CL:0000624"	"PR:000001020, PR:000029630"	"2"	"2"	"12"	"114"	"28687661_12_114"
""	"dendritic cell & CD11c+; plasmacytoid dendritic cell"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"CD11c-positive DC; plasmacytoid dendritic cell"	"cell type frequency"	"up"	"86d vs 0d"	"time of vaccination (first dose)"	"86"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"text, Fig 4B-C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/"	""	"CL:0000451"	"PR:000001013"	"2"	"2"	"13"	"115"	"28687661_13_115"
""	"B cell & CD3-, CD19+, CD20+"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"B cells CD3-/CD19+CD20+"	"cell type frequency"	"up"	"14d vs 0d"	"time of vaccination (first dose)"	"14"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 5A"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/"	""	"CL:0000236"	"PR:000001020, PR:000001002, PR:000001289"	"1"	"1"	"14"	"116"	"28687661_14_116"
""	"dendritic cell & CD11c+, HLA-DR+"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"DC HLA-DR+CD11c+"	"cell type frequency"	"down"	"flavivirus infected vs naive participants"	"time of vaccination (first dose)"	"14"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 6a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F6/"	""	"CL:0000451"	"PR:000001013"	"1"	"1"	"15"	"117"	"28687661_15_117"
""	"dendritic cell & CD11c+, HLA-DR+"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"DC HLA-DR+CD11c+"	"cell type frequency"	"down"	"flavivirus infected vs naive participants"	"time of vaccination (first dose)"	"28"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 6a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F6/"	""	"CL:0000451"	"PR:000001013"	"1"	"1"	"16"	"118"	"28687661_16_118"
""	"natural killer cell & CD107a+, K562 cells"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"NK cells NK/CD107a+/K562"	"cell type frequency"	"up"	"flavivirus infected vs naive participants"	"time of vaccination (first dose)"	"28"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 6b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F6/"	""	"CL:0000623"	"PR:000002060"	"1"	"1"	"17"	"119"	"28687661_17_119"
""	"natural killer cell & TNF-a+, K562 cells"	""	""	"25"	"42"	"years"	""	"peripheral blood mononuclear cell"	"CL:2000001"	"NK cells NK/TNFa+/K562"	"cell type frequency"	"up"	"flavivirus infected vs naive participants"	"time of vaccination (first dose)"	"86"	"days"	"YF-17D"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"28687661"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/"	"Fig 6b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F6/"	""	"CL:0000623"	"PR:000000134"	"1"	"1"	"18"	"120"	"28687661_18_120"
""	"CD8-positive, alpha-beta T cell & GZMB+, TIV-specific"	""	""	"18"	"45"	"years"	"60"	"blood serum"	"UBERON:0001977"	"TIV-specific CD8+ GRZ+ T lymphocyte cells"	"cell type frequency"	"up"	"S2 vs S1 as defined by hierarchical clustering of gene expression"	"time of vaccination (first dose)"	"21"	"days"	"2012-2013 seasonal trivalent inactivated influenza vaccine (TIV)"	"VO:0004899"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Victoria/361/2011(H3N2)); influenza B virus (B/Wisconsin/01/2010)"	"2012"	""	""	""	"30843873"	"2019"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/"	"Fig 4e"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/figure/F4/"	"Clusters S1 and S2 were defined based on hierarchical clustering of gene expression and were shown to be enriched with significantly different levels of influenza specific MN antibodies as well as vaccination routes for d21/d0."	"CL:0000625"	"PR:000003499"	"1"	"1"	"1"	"121"	"30843873_1_121"
""	"CD8-positive, alpha-beta T cell & GZMB+, TIV-specific"	""	""	"18"	"45"	"years"	"60"	"blood serum"	"UBERON:0001977"	"T cell responder TIV-specific CD8+ GRZ+"	"cell type frequency"	"up"	"S2 vs S1 as defined by hierarchical clustering of gene expression"	"time of vaccination (first dose)"	"21"	"days"	"2012-2013 seasonal trivalent inactivated influenza vaccine (TIV)"	"VO:0004899"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Victoria/361/2011(H3N2)); influenza B virus (B/Wisconsin/01/2010)"	"2012"	""	""	""	"30843873"	"2019"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/"	"Fig 3f"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/figure/F3/"	"Clusters S1 and S2 were defined based on hierarchical clustering of gene expression and were shown to be enriched with significantly different levels of influenza specific MN antibodies as well as vaccination routes for d21/d0."	"CL:0000625"	"PR:000003499"	"1"	"1"	"2"	"122"	"30843873_2_122"
""	"myeloid dendritic cell & CD86-positive"	""	""	"18"	"45"	"years"	"15"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD86+ myeloid dendritic cell (DC)"	"cell type frequency"	"up"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"YF-17D vaccine"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"19029902"	"2009"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/"	"Suppl Fig 1c"	""	""	"CL:0000782"	"PR:000001412"	"1"	"1"	"1"	"123"	"19029902_1_123"
""	"myeloid dendritic cell & CD86-positive"	""	""	"18"	"45"	"years"	"15"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD86+ myeloid dendritic cell (DC)"	"cell type frequency"	"up"	"3d vs 1d"	"time of vaccination (first dose)"	"3"	"days"	"YF-17D vaccine"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"19029902"	"2009"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/"	"Suppl Fig 1c"	""	""	"CL:0000782"	"PR:000001412"	"1"	"1"	"2"	"124"	"19029902_2_124"
""	"myeloid dendritic cell & CD86-positive; monocyte & CD86+"	""	""	"18"	"45"	"years"	"15"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD86+ myeloid dendritic cell (DC); CD86+ monocyte"	"cell type frequency"	"up"	"3d vs 0d"	"time of vaccination (first dose)"	"3"	"days"	"YF-17D vaccine"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"19029902"	"2009"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/"	"Suppl Fig 1c"	""	""	"CL:0000782"	"PR:000001412"	"2"	"2"	"3"	"125"	"19029902_3_125"
""	"myeloid dendritic cell & CD86-positive"	""	""	"18"	"45"	"years"	"15"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD86+ myeloid dendritic cell (DC)"	"cell type frequency"	"up"	"21d vs 7d"	"time of vaccination (first dose)"	"21"	"days"	"YF-17D vaccine"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"19029902"	"2009"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/"	"Suppl Fig 1c"	""	""	"CL:0000782"	"PR:000001412"	"1"	"1"	"4"	"126"	"19029902_4_126"
""	"plasmacytoid dendritic cell & CD86+; monocyte & CD86-positive, CD16-positive, inflammatory"	""	""	"18"	"45"	"years"	"15"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD86+ plasmacytoid dendritic cell (pDC); CD86+ CD16+ inflammatory monocyte"	"cell type frequency"	"up"	"7d vs 1d"	"time of vaccination (first dose)"	"7"	"days"	"YF-17D vaccine"	"VO:0003134"	""	"yellow fever virus 17D"	""	""	""	""	"19029902"	"2009"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/"	"Suppl Fig 1c"	""	""	"CL:0000784"	"PR:000001412 "	"2"	"2"	"5"	"127"	"19029902_5_127"
""	"CD4-positive, alpha-beta T cell"	""	""	"50"	"74"	"years"	"135"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD4+ T cells"	"cell type frequency"	"up"	"females vs males"	"time of vaccination (first dose)"	"0"	"days"	"Fluarix"	"VO:0000045"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"30873150"	"2019"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400991/"	"Fig 4b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400991/figure/F4/"	"Caucasion older adults (50-74)"	"CL:0000624"	""	"1"	"1"	"1"	"128"	"30873150_1_128"
""	"natural killer cell"	""	""	"50"	"74"	"years"	"135"	"peripheral blood mononuclear cell"	"CL:2000001"	"NK cell"	"cell type frequency"	"up"	"males vs females"	"time of vaccination (first dose)"	"0"	"days"	"Fluarix"	"VO:0000045"	""	"influenza A virus (A/California/7/2009(H1N1)); influenza A virus (A/Perth/16/2009(H3N2)); influenza B virus (B/Brisbane/60/2008)"	"2010"	""	""	""	"30873150"	"2019"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400991/"	"Fig 4b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400991/figure/F4/"	"Caucasion older adults (50-74)"	"CL:0000623"	""	"1"	"1"	"2"	"129"	"30873150_2_129"
""	"CD4-positive, alpha-beta T cell & IFNG+, VZV-specific"	""	""	"70"	"93"	"years"	"30"	"blood"	"UBERON:0000178"	"T cells IFNg producing VZV-specific CD4+"	"cell type frequency"	"up"	"pre-vaccination vs 72hrs post-vaccination"	"time of VZV antigen challenge"	"72"	"hours"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"Fig 2e"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F2/"	"2:1 ratio of female:male"	"CL:0000624"	"PR:000000017"	"1"	"1"	"1"	"130"	"30247603_1_130"
""	"CD4-positive, alpha-beta T cell; CD8-positive, alpha-beta T cell"	""	""	"70"	"93"	"years"	"30"	"skin of body"	"UBERON:0002097"	"T cells CD4+; T cells CD8+"	"cell type frequency"	"up"	"pre-vaccination vs 3d post-VZV antigen challenge"	"time of VZV antigen challenge"	"3"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"Fig 3a-c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F3/"	"2:1 ratio of female:male"	"CL:0000624"	""	"2"	"2"	"2"	"131"	"30247603_2_131"
""	"CD8-positive, alpha-beta T cell & pKI-67+"	""	""	"70"	"93"	"years"	"30"	"skin of body"	"UBERON:0002097"	"T cells CD8+ Ki67+"	"cell type frequency"	"up"	"pre-vaccination vs 3d post-VZV antigen challenge"	"time of VZV antigen challenge"	"3"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"Fig 4b-c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F4/"	"2:1 ratio of female:male"	"CL:0000625"	"PR:000029630"	"1"	"1"	"3"	"132"	"30247603_3_132"
""	"CD4-positive, alpha-beta T cell; CD8-positive, alpha-beta T cell"	""	""	"70"	"93"	"years"	"30"	"skin of body"	"UBERON:0002097"	"T cells CD4+; T cells CD8+"	"cell type frequency"	"up"	"pre-vaccination vs 7d post-VZV antigen challenge"	"time of VZV antigen challenge"	"7"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"Fig 3a-c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F3/"	"2:1 ratio of female:male"	"CL:0000624"	""	"2"	"2"	"4"	"133"	"30247603_4_133"
""	"CD8-positive, alpha-beta T cell & pKI-67+"	""	""	"70"	"93"	"years"	"30"	"skin of body"	"UBERON:0002097"	"T cells CD8+ Ki67+"	"cell type frequency"	"up"	"pre-vaccination vs 7d post-VZV antigen challenge"	"time of VZV antigen challenge"	"7"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"Fig 4b-c"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F4/"	"2:1 ratio of female:male"	"CL:0000625"	"PR:000029630"	"1"	"1"	"5"	"134"	"30247603_5_134"
""	"regulatory T cell & FOXP3+"	""	""	"70"	"93"	"years"	"30"	"skin of body"	"UBERON:0002097"	"T cells CD4+ Tregs Foxp3+"	"cell type frequency"	"down"	"pre-vaccination vs 3d post-VZV antigen challenge"	"time of VZV antigen challenge"	"3"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"Fig 4e"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F4/"	"2:1 ratio of female:male"	"CL:0000815"	"PR:000001350 "	"1"	"1"	"6"	"135"	"30247603_6_135"
""	"regulatory T cell & FOXP3+"	""	""	"70"	"93"	"years"	"30"	"skin of body"	"UBERON:0002097"	"T cells CD4+ Tregs Foxp3+"	"cell type frequency"	"down"	"pre-vaccination vs 7d post-VZV antigen challenge"	"time of VZV antigen challenge"	"7"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"Fig 4e"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F4/"	"2:1 ratio of female:male"	"CL:0000815"	"PR:000001350 "	"1"	"1"	"7"	"136"	"30247603_7_136"
""	"natural killer cell & CD3-, CD56-dim"	""	"subgroup high antibody responders"	"18"	"45"	"years"	"14"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD3- CD56dim Natural Killer cells"	"cell type frequency"	"up"	"14d vs 0hr"	"time of vaccination (first dose)"	"14"	"days"	"CN54gp140"	"VO:0004891"	""	"human immunodeficiency virus 1"	""	"GLA-AF"	""	""	"29535712"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834766/"	"Fig 4"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834766/figure/F4/"	"1 intramuscular dose"	"CL:0000623"	"PR:000001020, PR:000001024"	"1"	"1"	"1"	"137"	"29535712_1_137"
""	"CD4-positive, alpha-beta memory T cell & VZV-specific"	""	""	"25"	"40"	"years"	"25"	"peripheral blood mononuclear cell"	"CL:2000001"	"memory T cells VZV-specific CD4+"	"cell type frequency"	"up"	"30d vs 0d"	"time of vaccination (first dose)"	"30"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	"CL:0000897"	""	"1"	"1"	"1"	"138"	"28607114_1_138"
""	"CD4-positive, alpha-beta memory T cell & VZV-specific"	""	""	"60"	"80"	"years"	"33"	"peripheral blood mononuclear cell"	"CL:2000001"	"memory T cells VZV-specific CD4+"	"cell type frequency"	"up"	"30d vs 0d"	"time of vaccination (first dose)"	"30"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	"CL:0000897"	""	"1"	"1"	"2"	"139"	"28607114_2_139"
""	"CD4-positive, alpha-beta memory T cell & VZV-specific"	""	""	"25"	"40"	"years"	"25"	"peripheral blood mononuclear cell"	"CL:2000001"	"memory T cells VZV-specific CD4+"	"cell type frequency"	"up"	"90d vs 0d"	"time of vaccination (first dose)"	"90"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	"CL:0000897"	""	"1"	"1"	"3"	"140"	"28607114_3_140"
""	"CD4-positive, alpha-beta memory T cell & VZV-specific"	""	""	"60"	"80"	"years"	"33"	"peripheral blood mononuclear cell"	"CL:2000001"	"memory T cells VZV-specific CD4+"	"cell type frequency"	"up"	"90d vs 0d"	"time of vaccination (first dose)"	"90"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	"CL:0000897"	""	"1"	"1"	"4"	"141"	"28607114_4_141"
""	"CD4-positive, alpha-beta memory T cell & VZV-specific"	""	""	"60"	"80"	"years"	"33"	"peripheral blood mononuclear cell"	"CL:2000001"	"memory T cells VZV-specific CD4+"	"cell type frequency"	"up"	"180d vs 0d"	"time of vaccination (first dose)"	"180"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	"CL:0000897"	""	"1"	"1"	"5"	"142"	"28607114_5_142"
""	"CD4-positive, alpha-beta memory T cell & VZV-specific"	""	"adults (25-40), seniors (60-80)"	"25"	"80"	"years"	"58"	"peripheral blood mononuclear cell"	"CL:2000001"	"memory T cells VZV-specific CD4+"	"cell type frequency"	"up"	"young adults vs old adults"	"time of vaccination (first dose)"	"0"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	"CL:0000897"	""	"1"	"1"	"6"	"143"	"28607114_6_143"
""	"CD4-positive, alpha-beta memory T cell & VZV-specific"	""	""	"25"	"80"	"years"	"58"	"peripheral blood mononuclear cell"	"CL:2000001"	"memory T cells VZV-specific CD4+"	"cell type frequency"	"down"	"young adults vs old adults"	"time of vaccination (first dose)"	"180"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 1a"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	"CL:0000897"	""	"1"	"1"	"7"	"144"	"28607114_7_144"
""	"CD4-positive, alpha-beta memory T cell & IL2+, BCL2+, VZV-specific"	""	""	"25"	"40"	"years"	"25"	"peripheral blood mononuclear cell"	"CL:2000001"	"memory T cells VZV-specific CD4+ IL2+ BCL2+"	"cell type frequency"	"up"	"30d vs 0d"	"time of vaccination (first dose)"	"30"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 1b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	"CL:0000897"	"PR:000001379, PR:000002307 "	"1"	"1"	"8"	"145"	"28607114_8_145"
""	"CD4-positive, alpha-beta memory T cell & IL2+, BCL2+, VZV-specific"	""	""	"60"	"80"	"years"	"33"	"peripheral blood mononuclear cell"	"CL:2000001"	"memory T cells VZV-specific CD4+ IL2+ BCL2+"	"cell type frequency"	"up"	"30d vs 0d"	"time of vaccination (first dose)"	"30"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 1b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	"CL:0000897"	"PR:000001379, PR:000002307 "	"1"	"1"	"9"	"146"	"28607114_9_146"
""	"CD4-positive, alpha-beta memory T cell & IL2+, BCL2+, VZV-specific"	""	""	"25"	"40"	"years"	"25"	"peripheral blood mononuclear cell"	"CL:2000001"	"memory T cells VZV-specific CD4+ IL2+ BCL2+"	"cell type frequency"	"down"	"180d vs 0d"	"time of vaccination (first dose)"	"180"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 1b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	"CL:0000897"	"PR:000001379, PR:000002307 "	"1"	"1"	"10"	"147"	"28607114_10_147"
""	"CD4-positive, alpha-beta memory T cell & IL2+, BCL2+, VZV-specific"	""	""	"60"	"80"	"years"	"33"	"peripheral blood mononuclear cell"	"CL:2000001"	"memory T cells VZV-specific CD4+ IL2+ BCL2+"	"cell type frequency"	"up"	"180d vs 0d"	"time of vaccination (first dose)"	"180"	"days"	"Zostavax"	"VO:0000124"	""	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 1b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/"	""	"CL:0000897"	"PR:000001379, PR:000002307 "	"1"	"1"	"11"	"148"	"28607114_11_148"
""	"CD8-positive, alpha-beta T cell & dual-function, VZV-specific"	""	""	"25"	"40"	"years"	"25"	"peripheral blood mononuclear cell"	"CL:2000001"	"T cells Dual-function VZV-specific CD8+"	"cell type frequency"	"up"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Zostavax"	"VO:0000124"	"ex-vivo restimulation with live VZV"	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 2b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F2/"	""	"CL:0000625"	""	"1"	"1"	"12"	"149"	"28607114_12_149"
""	"CD8-positive, alpha-beta T cell & CD69+, VZV-specific, CD57+"	""	""	"25"	"80"	"years"	"58"	"peripheral blood mononuclear cell"	"CL:2000001"	"VZV-specific CD8+ CD69+ CD57+ cells"	"cell type frequency"	"up"	"old adults vs young adults"	"time of vaccination (first dose)"	"0"	"days"	"Zostavax"	"VO:0000124"	"ex-vivo restimulation with live VZV"	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 3a-b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F3/"	""	"CL:0000625"	"PR:000001343"	"1"	"1"	"13"	"150"	"28607114_13_150"
""	"CD8-positive, alpha-beta T cell & CD69+, PD-1+, VZV-specific"	""	""	"25"	"80"	"years"	"58"	"peripheral blood mononuclear cell"	"CL:2000001"	"VZV-specific CD8+ CD69+ PD1+ cells"	"cell type frequency"	"up"	"old adults vs young adults"	"time of vaccination (first dose)"	"0"	"days"	"Zostavax"	"VO:0000124"	"ex-vivo restimulation with live VZV"	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 3a-b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F3/"	""	"CL:0000625"	"PR:000001343, PR:000001919"	"1"	"1"	"14"	"151"	"28607114_14_151"
""	"CD8-positive, alpha-beta T cell & CD69+, VZV-specific, CD57+"	""	""	"25"	"80"	"years"	"58"	"peripheral blood mononuclear cell"	"CL:2000001"	"VZV-specific CD8+ CD69+ CD57+ cells"	"cell type frequency"	"up"	"old adults vs young adults"	"time of vaccination (first dose)"	"7"	"days"	"Zostavax"	"VO:0000124"	"ex-vivo restimulation with live VZV"	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 3b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F3/"	""	"CL:0000625"	"PR:000001343"	"1"	"1"	"15"	"152"	"28607114_15_152"
""	"CD8-positive, alpha-beta T cell & CD69+, VZV-specific, CD57+"	""	""	"25"	"80"	"years"	"58"	"peripheral blood mononuclear cell"	"CL:2000001"	"VZV-specific CD8+ CD69+ CD57+ cells"	"cell type frequency"	"up"	"old adults vs young adults"	"time of vaccination (first dose)"	"30"	"days"	"Zostavax"	"VO:0000124"	"ex-vivo restimulation with live VZV"	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 3b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F3/"	""	"CL:0000625"	"PR:000001343"	"1"	"1"	"16"	"153"	"28607114_16_153"
""	"CD4-positive, alpha-beta T cell & CD69+, PD-1+, CD57+, VZV-specific"	""	"subgroup older adults"	"60"	"80"	"years"	"33"	"peripheral blood mononuclear cell"	"CL:2000001"	"VZV-specific CD4+ CD69+ CD57+ PD1+ cells"	"cell type frequency"	"negatively correlated"	"VZV-specific RCF post-vaccination at 30d vs 0d"	"time of vaccination (first dose)"	"30"	"days"	"Zostavax"	"VO:0000124"	"ex-vivo restimulation with live VZV"	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 4"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F4/"	""	"CL:0000624"	"PR:000001343, PR:000001919"	"1"	"1"	"17"	"154"	"28607114_17_154"
""	"CD8-positive, alpha-beta cytotoxic T cell & CD107a+, IFNg+, VZV-specific"	""	"subgroup older adults"	"60"	"80"	"years"	"33"	"peripheral blood mononuclear cell"	"CL:2000001"	"cytotoxic T lymphocytes VZV-specific CD8+ IFNg+ CD107a+"	"cell type frequency"	"negatively correlated"	"VZV-specific CD8+CD69+CD57+PD1+ at 7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Zostavax"	"VO:0000124"	"ex-vivo restimulation with live VZV"	"human alphaherpesvirus 3"	""	""	""	""	"28607114"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/"	"Fig 4"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F4/"	""	"CL:0000794"	"PR:000002060, PR:000000017"	"1"	"1"	"18"	"155"	"28607114_18_155"
""	"neutrophil; monocyte"	""	""	"18"	"49"	"years"	"20"	"blood"	"UBERON:0000178"	"neutrophil; monocyte"	"cell type frequency"	"up"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"inactivated monovalent influenza A/Indonesia/05/2005 H5N1 split-virus vaccine"	"VO:0004903"	""	"influenza A virus (A/Indonesia/5/2005(H5N1))"	"2005mv"	"AS03 (VO_0001320)"	"subcutaneous"	""	"28099485"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242433/"	"Fig A212-213 and Tables A161-A162 in S2 Text"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242433/#pone.0167488.s012"	""	"CL:0000775"	""	"2"	"2"	"1"	"156"	"28099485_1_156"
""	"monocyte; dendritic cell"	""	""	"18"	"49"	"years"	"20"	"blood"	"UBERON:0000178"	"monocyte; dendritic cell"	"cell type frequency"	"up"	"3d vs 0d"	"time of vaccination (first dose)"	"3"	"days"	"inactivated monovalent influenza A/Indonesia/05/2005 H5N1 split-virus vaccine"	"VO:0004903"	""	"influenza A virus (A/Indonesia/5/2005(H5N1))"	"2005mv"	"AS03 (VO_0001320)"	"subcutaneous"	""	"28099485"	"2017"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242433/"	"Fig A212-213 and Tables A161-A162 in S2 Text"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242433/#pone.0167488.s012"	""	"CL:0000576"	""	"2"	"2"	"2"	"157"	"28099485_2_157"
""	"CD14-positive, CD16-positive monocyte & HLA-DR++; B cell & CD19+, CD69+; CD8-positive, alpha-beta T cell & CXCR4+; CD8-positive, alpha-beta T cell & CD69+; CD4-positive, alpha-beta T cell & CCR5+; CD4-positive, alpha-beta T cell & CD54+; CD4-positive, alpha-beta T cell & CD69+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"CD16+ HLA-DR++ CD14+ monocytes; CD69+ CD19+ B-cells; CXCR4+ CD8+ T-cells; CD69+ CD8+ T-cells; CCR5+ CD4+ T-cells; CD54+ CD4+ T-cells; CD69+ CD4+ T-cells"	"cell type frequency"	"up"	"3d vs 0d"	"time of vaccination (first dose)"	"3"	"days"	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO:0000160"	""	"influenza A virus (A/California/7/2009(H1N1))"	"2009mv"	""	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0002397"	""	"7"	"7"	"1"	"158"	"28549970_1_158"
""	"natural killer cell & CD56+, CD16+; natural killer cell & CD16+, CD56+, CD3+; CD4-positive, alpha-beta T cell & HLA-DR+; CD8-positive, alpha-beta T cell & HLA-DR+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"CD16+ CD56+ CD3- Natural Killer cells; CD16+ CD56+ CD3+ Natural Killer cells; HLA-DR+ CD4+ T-cells; HLA-DR+ CD8+ T-cells"	"cell type frequency"	"down"	"3d vs 0d"	"time of vaccination (first dose)"	"3"	"days"	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO:0000160"	""	"influenza A virus (A/California/7/2009(H1N1))"	"2009mv"	""	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0000623"	"PR:000001024, PR:000001483"	"4"	"4"	"2"	"159"	"28549970_2_159"
""	"B cell & CD19+, CD69+; CD4-positive, alpha-beta T cell & CCR3+; CD4-positive, alpha-beta T cell & CCR5+; CD8-positive, alpha-beta T cell & CXCR4+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"CD69+ CD19+ B-cells; CCR3+ CD4+ T-cells; CCR5+ CD4+ T-cells; CXCR4+ CD8+ T-cells"	"cell type frequency"	"up"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO:0000160"	""	"influenza A virus (A/California/7/2009(H1N1))"	"2009mv"	""	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0000236"	"PR:000001002, PR:000001343"	"4"	"4"	"3"	"160"	"28549970_3_160"
""	"CD14-positive, CD16-positive monocyte & HLA-DR++; CD14-positive monocyte & CCR2+; natural killer cell & CD16+, CD56+, CD3+; CD4-positive, alpha-beta T cell & CD69+; CD4-positive, CD25-positive, alpha-beta regulatory T cell & CD25-hi; CD4-positive, alpha-beta T cell & HLA-DR+; CD8-positive, alpha-beta T cell & HLA-DR+; CD8-positive, alpha-beta T cell & CD38+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"HLA-DR++ CD16+ CD14+ monocytes; CCR2+ CD14+ monocytes; CD16+ CD56+ CD3+ Natural Killer cells; CD69+ CD4+ T-cells; CD25high CD4+ T-cells; HLA-DR+ CD4+ T-cells; HLA-DR+ CD8+ T-cells; CD38+ CD8+ T-cells"	"cell type frequency"	"down"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO:0000160"	""	"influenza A virus (A/California/7/2009(H1N1))"	"2009mv"	""	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0002397"	""	"8"	"8"	"4"	"161"	"28549970_4_161"
""	"CD14-positive, CD16-positive monocyte & HLA-DR++; CD4-positive, CD25-positive, alpha-beta regulatory T cell; CD4-positive, alpha-beta T cell & CCR3+; CD4-positive, alpha-beta T cell & CCR5+; CD4-positive, alpha-beta T cell & CXCR3+; CD8-positive, alpha-beta T cell & CD69+; CD8-positive, CD25-positive, alpha-beta regulatory T cell; CD8-positive, alpha-beta T cell & CCR3+; B cell, CD19-positive & CD5+; B cell & CD19+, CD69+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"HLA-DR++ CD16+ CD14+ monocytes; CD25+ CD4+ T-cells; CCR3+ CD4+ T-cells; CCR5+ CD4+ T-cells; CXCR3+ CD4+ T-cells; CD69+ CD8+ T-cells; CD25+ CD8+ T-cells; CCR3+ CD8+ T-cells; CD5+ CD19+ B-cells; CD69+ CD19+ B-cells"	"cell type frequency"	"up"	"30d vs 0d"	"time of vaccination (first dose)"	"30"	"days"	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO:0000160"	""	"influenza A virus (A/California/7/2009(H1N1))"	"2009mv"	""	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0002397"	""	"10"	"10"	"5"	"162"	"28549970_5_162"
""	"CD4-positive, alpha-beta T cell & CD54+; CD4-positive, alpha-beta T cell & CXCR4+; CD8-positive, alpha-beta T cell & CD38+; CD14-positive monocyte & CCR5+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"CD54+ CD4+ T-cells; CXCR4+ CD4+ T-cells; CD38+ CD8+ T-cells; CCR5+ CD14+ monocytes"	"cell type frequency"	"down"	"30d vs 0d"	"time of vaccination (first dose)"	"30"	"days"	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO:0000160"	""	"influenza A virus (A/California/7/2009(H1N1))"	"2009mv"	""	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0000624"	"PR:000001467"	"4"	"4"	"6"	"163"	"28549970_6_163"
""	"CD14-positive monocyte & CD64+; CD14-positive monocyte & CCR2+; CD14-positive monocyte & CCR5+; CD14-positive monocyte; B cell & CD19+; B cell, CD19-positive & CD5+; CD4-positive, alpha-beta T cell & CD69+; CD4-positive, alpha-beta T cell & HLA-DR+; CD4-positive, alpha-beta T cell & CCR3+; CD4-positive, alpha-beta T cell & CCR5+; CD4-positive, alpha-beta T cell & CXCR4+; CD8-positive, alpha-beta T cell & HLA-DR+; CD8-positive, alpha-beta T cell & CXCR3+; CD8-positive, alpha-beta T cell & CXCR4+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"CD64+ CD14+ monocytes; CCR2+ CD14+ monocytes; CCR5+ CD14+ monocytes; CD14+ monocytes; CD19+ B-cells; CD5+ CD19+ B-cells; CD69+ CD4+ T-cells; HLA-DR+ CD4+ T-cells; CCR3+ CD4+ T-cells; CCR5+ CD4+ T-cells; CXCR4+ CD4+ T-cells; HLA-DR+ CD8+ T-cells; CXCR3+ CD8+ T-cells; CXCR4+ CD8+ T-cells"	"cell type frequency"	"up"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (VO_0001320)"	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: black bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0001054"	""	"14"	"14"	"7"	"164"	"28549970_7_164"
""	"CD8-positive, alpha-beta T cell & HLA-DR+; CD8-positive, alpha-beta T cell & CD69+; CD8-positive, alpha-beta T cell & CXCR4+; B cell & CD19+, CD69+; CD4-positive, alpha-beta T cell & HLA-DR+; CD4-positive, alpha-beta T cell & CD69+; CD4-positive, alpha-beta T cell & CXCR4+; CD4-positive, alpha-beta T cell & CCR3+; natural killer cell & CD16+, CD56+, CD3+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"HLA-DR+ CD8+ T-cells; CD69+ CD8+ T-cells; CXCR4+ CD8+ T-cells; CD19+ CD69+ B-cells; HLA-DR+ CD4+ T-cells; CD69+ CD4+ T-cells; CXCR4+ CD4+ T-cells; CCR3+ CD4+ T-cells; CD16+ CD56+ CD3+ Natural Killer cells"	"cell type frequency"	"down"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)"	"VO:0000160"	""	"influenza A virus (A/California/7/2009(H1N1))"	"2009mv"	""	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0000625"	""	"9"	"9"	"8"	"165"	"28549970_8_165"
""	"CD14-positive, CD16-positive monocyte & HLA-DR++; CD14-positive monocyte & CD64+; CD4-positive, alpha-beta T cell & CD69+; CD4-positive, alpha-beta T cell & CD54+; CD4-positive, alpha-beta T cell & CCR5+; CD4-positive, alpha-beta T cell & CXCR3+; CD8-positive, alpha-beta T cell & CD69+; CD8-positive, CD25-positive, alpha-beta regulatory T cell; CD8-positive, alpha-beta T cell & CCR3+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"HLA-DR++ CD16+ CD14+ monocytes; CD64+ CD14+ monocytes; CD69+ CD4+ T-cells; CD54+ CD4+ T-cells; CCR5+ CD4+ T-cells; CXCR3+ CD4+ T-cells; CD69+ CD8+ T-cells; CD25+ CD8+ T-cells; CCR3+ CD8+ T-cells"	"cell type frequency"	"up"	"3d vs 0d"	"time of vaccination (first dose)"	"3"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (VO_0001320)"	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0002397"	""	"9"	"9"	"9"	"166"	"28549970_9_166"
""	"B cell & CD19+, CD69+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"CD69+ CD19+ B-cells"	"cell type frequency"	"down"	"3d vs 0d"	"time of vaccination (first dose)"	"3"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (VO_0001320)"	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: grey bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0000236"	"PR:000001002, PR:000001343"	"1"	"1"	"10"	"167"	"28549970_10_167"
""	"CD14-positive, CD16-positive monocyte & HLA-DR++; CD14-positive monocyte & CCR2+; CD4-positive, alpha-beta T cell & CD69+; CD4-positive, alpha-beta T cell & HLA-DR+; CD4-positive, alpha-beta T cell & CXCR3+; CD8-positive, alpha-beta T cell & CD69+; CD8-positive, CD25-positive, alpha-beta regulatory T cell; CD8-positive, alpha-beta T cell & HLA-DR+; CD8-positive, alpha-beta T cell & CCR3+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"HLA-DR++ CD16+ CD14+ monocytes; CCR2+ CD14+ monocytes; CD69+ CD4+ T-cells; HLA-DR+ CD4+ T-cells; CXCR3+ CD4+ T-cells; CD69+ CD8+ T-cells; CD25+ CD8+ T-cells; HLA-DR+ CD8+ T-cells; CCR3+ CD8+ T-cells"	"cell type frequency"	"up"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (VO_0001320)"	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: black bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0002397"	""	"9"	"9"	"11"	"168"	"28549970_11_168"
""	"natural killer cell & CD16+, CD56+, CD3+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"CD16+ CD56+ CD3+ Natural Killer cells"	"cell type frequency"	"down"	"7d vs 0d"	"time of vaccination (first dose)"	"7"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (VO_0001320)"	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: black bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0000623"	"PR:000001483, PR:000001024, PR:000001020 "	"1"	"1"	"12"	"169"	"28549970_12_169"
""	"CD14-positive, CD16-positive monocyte & HLA-DR++; CD14-positive monocyte & CD64+; CD14-positive monocyte & CCR2+; natural killer cell & CD56+, CD16+; CD4-positive, alpha-beta T cell & CXCR4+; CD8-positive, alpha-beta T cell & CXCR4+; B cell & CD32+, CD19+; CD8-positive, alpha-beta T cell & CD69+; CD8-positive, CD25-positive, alpha-beta regulatory T cell; CD8-positive, alpha-beta T cell & CCR3+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"HLA-DR++ CD16+ CD14+ monocytes; CD64+ CD14+ monocytes; CCR2+ CD14+ monocytes; CD16+ CD56+ CD3- Natural Killer cells; CXCR4+ CD4+ T-cells; CXCR4+ CD8+ T-cells; CD32+ CD19+ B-cells; CD69+ CD8+ T-cells; CD25+ CD8+ T-cells; CCR3+ CD8+ T-cells"	"cell type frequency"	"up"	"30d vs 0d"	"time of vaccination (first dose)"	"30"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (VO_0001320)"	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: black bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0002397"	""	"10"	"10"	"13"	"170"	"28549970_13_170"
""	"CD14-positive monocyte & (total); CD14-positive monocyte & CCR5+; natural killer cell & CD16+, CD56+, CD3+; CD4-positive, alpha-beta T cell & CD54+; CD4-positive, alpha-beta T cell & CCR3+; CD4-positive, alpha-beta T cell & CXCR4+; CD8-positive, alpha-beta T cell & CD54+"	""	""	"21"	"51"	"years"	"20"	"blood"	"UBERON:0000178"	"total CD14+ monocytes; CCR5+ CD14+ monocytes; CD16+ CD56+ CD3+ Natural Killer cells; CD54+ CD4+ T-cells; CCR3+ CD4+ T-cells; CXCR4+ CD4+ T-cells; CD54+ CD8+ T-cells"	"cell type frequency"	"down"	"30d vs 0d"	"time of vaccination (first dose)"	"30"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (VO_0001320)"	"subcutaneous"	""	"28549970"	"2017"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub"	"Fig 2: black bars"	"https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2"	""	"CL:0001054"	""	"7"	"7"	"14"	"171"	"28549970_14_171"
""	"plasma cell"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"plasma cells"	"cell type frequency"	"up"	"1d vs -7d"	"time of vaccination (first dose)"	"1"	"day"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Fig 1C-D, Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F1/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000786"	""	"1"	"1"	"1"	"172"	"26726811_1_172"
""	"monocyte; monocyte & CD16-positive, inflammatory"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"monocytes; CD16+ inflammatory monocytes"	"cell type frequency"	"up"	"1d  vs  prevax"	"time of vaccination (first dose)"	"1"	"day"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Fig 1C-D, Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F1/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000576"	""	"2"	"2"	"2"	"173"	"26726811_2_173"
""	"T cell; gamma-delta T cell; CD8-positive, alpha-beta T cell; CD4-positive, alpha-beta T cell"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"all T-cells; gamma-delta cells; CD8+ T cells; CD4+ T cells"	"cell type frequency"	"down"	"1d  vs  prevax"	"time of vaccination (first dose)"	"1"	"day"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Fig 1C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F1/"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000084"	""	"4"	"4"	"3"	"174"	"26726811_3_174"
""	"plasma cell"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"plasma cell"	"cell type frequency"	"up"	"7d  vs  prevax"	"time of vaccination (first dose)"	"7"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Fig 1D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F1/"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000786"	""	"1"	"1"	"4"	"175"	"26726811_4_175"
""	"gamma-delta T cell & CD69+; natural killer cell & CD69+"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell"	"cell type frequency"	"up"	"non-responders vs responders"	"time of vaccination (first dose)"	"-7"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 6D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000798"	"PR:000001343"	"2"	"2"	"5"	"176"	"26726811_5_176"
""	"CD8-positive, alpha-beta T cell & IFNG+, CXCR3+"	""	"subgroup < 35 yo"	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CXCR3+ CD8+ IFN-gamma producing T-cells"	"cell type frequency"	"down"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 5B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000625"	"PR:000000017"	"1"	"1"	"6"	"177"	"26726811_6_177"
""	"CD8-positive, alpha-beta T cell & IFNG+, CXCR3+"	""	"subgroup < 35 yo"	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CXCR3+ CD8+ IFN-gamma producing T-cells"	"cell type frequency"	"down"	"1d vs -7d"	"time of vaccination (first dose)"	"1"	"day"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 5B"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000625"	"PR:000000017"	"1"	"1"	"7"	"178"	"26726811_7_178"
""	"gamma-delta T cell & CD69+; natural killer cell & CD69+"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell"	"cell type frequency"	"up"	"non-responders vs responders"	"time of vaccination (first dose)"	"0"	"day"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 6D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000798"	"PR:000001343"	"2"	"2"	"8"	"179"	"26726811_8_179"
""	"gamma-delta T cell & CD69+; natural killer cell & CD69+"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell"	"cell type frequency"	"up"	"non-responders vs responders"	"time of vaccination (first dose)"	"1"	"day"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 6D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000798"	"PR:000001343"	"2"	"2"	"9"	"180"	"26726811_9_180"
""	"gamma-delta T cell & CD69+; natural killer cell & CD69+"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell"	"cell type frequency"	"up"	"non-responders vs responders"	"time of vaccination (first dose)"	"7"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 6D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000798"	"PR:000001343"	"2"	"2"	"10"	"181"	"26726811_10_181"
""	"gamma-delta T cell & CD69+; natural killer cell & CD69+"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell"	"cell type frequency"	"up"	"non-responders vs responders"	"time of vaccination (first dose)"	"14"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 6D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000798"	"PR:000001343"	"2"	"2"	"11"	"182"	"26726811_11_182"
""	"gamma-delta T cell & CD69+; natural killer cell & CD69+"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell"	"cell type frequency"	"up"	"1d vs -7d"	"time of vaccination (first dose)"	"63"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 6D"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000798"	"PR:000001343"	"2"	"2"	"12"	"183"	"26726811_12_183"
""	"CD8-positive, alpha-beta T cell & CD38+"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD38+ CD8+ T-cells"	"cell type frequency"	"down"	"-7d vs 0d, negatively correlated with age"	"time of vaccination (first dose)"	"0"	"day"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000625"	"PR:000001408"	"1"	"1"	"13"	"184"	"26726811_13_184"
""	"central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+; central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells"	"cell type frequency"	"up"	"<35yr old vs >35yr old"	"time of vaccination (first dose)"	"-7"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000904"	"PR:000001017, PR:000001203"	"2"	"2"	"14"	"185"	"26726811_14_185"
""	"central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+; central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells"	"cell type frequency"	"up"	"<35yr old vs >35yr old"	"time of vaccination (first dose)"	"0"	"day"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000904"	"PR:000001017, PR:000001203"	"2"	"2"	"15"	"186"	"26726811_15_186"
""	"central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+; central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells"	"cell type frequency"	"up"	"<35yr old vs >35yr old"	"time of vaccination (first dose)"	"1"	"day"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000904"	"PR:000001017, PR:000001203"	"2"	"2"	"16"	"187"	"26726811_16_187"
""	"central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+; central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells"	"cell type frequency"	"up"	"<35yr old vs >35yr old"	"time of vaccination (first dose)"	"7"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000904"	"PR:000001017, PR:000001203"	"2"	"2"	"17"	"188"	"26726811_17_188"
""	"central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+; central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells"	"cell type frequency"	"up"	"<35yr old vs >35yr old"	"time of vaccination (first dose)"	"14"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000904"	"PR:000001017, PR:000001203"	"2"	"2"	"18"	"189"	"26726811_18_189"
""	"central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+; central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells"	"cell type frequency"	"up"	"<35yr old vs >35yr old"	"time of vaccination (first dose)"	"63"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 5C"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000904"	"PR:000001017, PR:000001203"	"2"	"2"	"19"	"190"	"26726811_19_190"
""	"CD8-positive, CXCR3-positive, alpha-beta regulatory T cell"	""	"subgroup < 35 yo"	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD8+ CXCR3+ alpha-beta regulatory T cell"	"cell type frequency"	"down"	"1d vs 0d"	"time of vaccination (first dose)"	"1"	"day"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Supp Fig 5b"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0001041"	""	"1"	"1"	"20"	"191"	"26726811_20_191"
""	"plasmablast & CD27+, CD38-hi"	""	""	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	"CL:2000001"	"CD27+ CD38hi plasmablasts"	"cell type frequency"	"up"	"responder vs non-responder"	"time of vaccination (first dose)"	"7"	"days"	"Pandemrix"	"VO:0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Fig 4d"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F4/"	"roughly 60/40 female:male ratio, over 70% were Causasian"	"CL:0000980"	"PR:000001963, PR:000001408"	"1"	"1"	"21"	"192"	"26726811_21_192"
